Document And Entity Information
Document And Entity Information | 6 Months Ended |
Jun. 30, 2023 | |
Document Information Line Items | |
Entity Registrant Name | MEDIGUS LTD. |
Document Type | 6-K |
Current Fiscal Year End Date | --12-31 |
Amendment Flag | false |
Entity Central Index Key | 0001618500 |
Document Period End Date | Jun. 30, 2023 |
Document Fiscal Year Focus | 2023 |
Document Fiscal Period Focus | Q2 |
Entity File Number | 001-37381 |
Interim Condensed Consolidated
Interim Condensed Consolidated Statements of Financial Position - USD ($) $ in Thousands | Jun. 30, 2023 | Dec. 31, 2022 |
CURRENT ASSETS: | ||
Cash and cash equivalents | $ 12,359 | $ 20,065 |
Short term deposits | 11 | 859 |
Restricted cash | 182 | 185 |
Trade accounts receivable | 18,981 | 21,449 |
Receivable from sale of shares | 5,774 | |
Other receivables | 2,015 | 1,928 |
Inventory | 2,543 | 1,791 |
Loans to associates | 1,181 | 546 |
Loans to others | 1,017 | 1,011 |
Related parties | 238 | 298 |
Financial assets at fair value through profit or loss | 2,243 | 4,126 |
Total current assets | 46,544 | 52,258 |
NON-CURRENT ASSETS: | ||
Property and equipment, net | 384 | 408 |
Right-of-use assets, net | 598 | 591 |
Investments accounted for using the equity method | 5,454 | 11,892 |
Intangible assets, net | 31,036 | 30,862 |
Deferred tax asset | 458 | 397 |
Financial assets at fair value through profit or loss | 1,193 | 1,243 |
Total non-current Assets | 39,123 | 45,393 |
TOTAL ASSETS | 85,667 | 97,651 |
CURRENT LIABILITIES: | ||
Trade accounts payable | 18,587 | 20,421 |
Short term loans | 5,973 | 5,111 |
Current portion of long-term loans | 1,879 | 1,500 |
Lease liabilities | 165 | 131 |
Warrants at fair value | 158 | 396 |
Liability to event producers | 1,526 | 1,654 |
Warrants at fair value issued by a subsidiary | 3,142 | 4,159 |
Related parties | 811 | 1,055 |
Accrued expenses and other current liabilities | 3,638 | 3,200 |
Total current liabilites | 35,879 | 37,627 |
NON-CURRENT LIABILITIES: | ||
Lease liabilities | 447 | 512 |
Long-term loans | 3,128 | 2,881 |
Deferred tax liability | 1,747 | 1,817 |
Accrued severance pay, net | 19 | 125 |
Total non-current liabilities | 5,341 | 5,335 |
TOTAL LIABILITIES | 41,220 | 42,962 |
EQUITY: | ||
Share capital - ordinary shares with no par value: authorized - June 30,2023 - 200,000,000 and December 31, 2022 - 200,000,000 shares; issued and outstanding - June 30, 2023 - 25,524,570 shares December 31, 2022 - 24,661,470 shares | ||
Share premium | 111,589 | 111,322 |
Other capital reserves | 13,763 | 13,208 |
Warrants | 197 | 197 |
Accumulated deficit | (93,786) | (85,586) |
Equity attributable to owners of Medigus Ltd. | 31,763 | 39,141 |
Non-controlling interests | 12,684 | 15,548 |
Total Equity | 44,447 | 54,689 |
TOTAL LIABILITIES AND EQUITY | $ 85,667 | $ 97,651 |
Interim Condensed Consolidate_2
Interim Condensed Consolidated Statements of Financial Position (Parentheticals) - $ / shares | Jun. 30, 2023 | Dec. 31, 2022 |
Statement of financial position [abstract] | ||
Ordinary shares, par value (in Dollars per share) | ||
Ordinary shares, shares authorized | 200,000,000 | 200,000,000 |
Ordinary shares, shares issued | 25,524,570 | 24,661,470 |
Ordinary shares, shares outstanding | 25,524,570 | 24,661,470 |
Interim Condensed Consolidate_3
Interim Condensed Consolidated Statements of Loss and Other Comprehensive Loss (Unaudited) - USD ($) $ in Thousands | 6 Months Ended | |
Jun. 30, 2023 | Jun. 30, 2022 | |
Revenues | ||
Products | $ 3,871 | $ 2,343 |
Services | 49,514 | 32,616 |
Revenue | 53,385 | 34,959 |
Cost of revenues: | ||
Products | 3,497 | 1,933 |
Services | 41,688 | 26,834 |
Cost of revenues | 45,185 | 28,767 |
Gross profit | 8,200 | 6,192 |
Research and development expenses | 2,632 | 2,500 |
Sales and marketing expenses | 1,868 | 2,240 |
General and administrative expenses | 8,274 | 5,057 |
Net change in fair value of financial assets at fair value through profit or loss | 3,978 | 813 |
Equity losses | 1,238 | 1,910 |
Operating loss | (9,790) | (6,328) |
Gain from initial recognition of assets and liabilities upon consolidation of Gix Internet | (2,300) | |
Loss from sale of investments | (68) | |
Other income | (154) | (176) |
Changes in fair value of warrants issued to investors | (238) | 99 |
Changes in fair value of warrants issued to third party investors by a consolidated subsidiary | (1,017) | 63 |
Financial loss, net | 978 | 793 |
Loss before taxes on income | (9,359) | (4,739) |
Tax expenses | (177) | (9) |
Net loss for the period | (9,536) | (4,748) |
Items that may be reclassified to profit or loss | ||
Share of other comprehensive income (loss) of consolidated subsidiaries and associates accounted for using the equity method | 306 | (961) |
Other comprehensive income (loss) for the period | 306 | (961) |
Total comprehensive loss for the period | (9,230) | (5,709) |
Net loss for the period is attributable to: | ||
Owners of Medigus | (8,200) | (3,590) |
Non-controlling interests | (1,336) | (1,158) |
Net profit (loss) for the year | (9,536) | (4,748) |
Total comprehensive loss for the period is attributable to: | ||
Owners of Medigus | (8,061) | (4,275) |
Non-controlling interests | (1,169) | (1,434) |
TOTAL COMREHENSIVE LOSS FOR THE YEAR | $ (9,230) | $ (5,709) |
Loss per ordinary share, Basic (in Dollars per share) | $ (0.33) | $ (0.15) |
Loss per ordinary share, Diluted (in Dollars per share) | $ (0.33) | $ (0.15) |
Weighted average ordinary shares outstanding, Basic (in Shares) | 24,490 | 24,109 |
Weighted average ordinary shares outstanding, Diluted (in Shares) | 24,490 | 24,109 |
Interim Condensed Consolidate_4
Interim Condensed Consolidated Statements of Changes in Equity - USD ($) $ in Thousands | Ordinary shares | Share premium | Capital reserves from options granted | Other reserves | Capital reserves from transactions with non- controlling interests | Currency translation differences | Warrants | Accumulated deficit | Total | Non- controlling interests | Total |
Balance beginning at Dec. 31, 2021 | $ 110,562 | $ 2,579 | $ 634 | $ 10,408 | $ (1,002) | $ 197 | $ (74,188) | $ 49,190 | $ 2,243 | $ 51,433 | |
Loss for the period | (3,590) | (3,590) | (1,158) | (4,748) | |||||||
Other comprehensive income loss | (685) | (685) | (276) | (961) | |||||||
TOTAL COMPREHENSIVE LOSS FOR THE PERIOD | (685) | (3,590) | (4,275) | (1,434) | (5,709) | ||||||
TRANSACTIONS WITH SHAREHOLDERS: | |||||||||||
Issuance of warrants and shares by Gix Internet | (713) | (713) | 811 | 98 | |||||||
Deemed contributions to Jeffs’ Brands | 121 | (356) | (235) | 478 | 243 | ||||||
Issuance of shares in consideration for an investment | 900 | 900 | 900 | ||||||||
Issuance of shares by Eventer | (20) | (20) | 20 | ||||||||
Consolidation of Gix Internet | (144) | (144) | 6,129 | 5,985 | |||||||
Divided paid to non-controlling interests | (391) | (391) | |||||||||
Subsidiaries’ share-based compensation to employees and service providers | 191 | 191 | |||||||||
Share based compensation to employees and service providers | 439 | 439 | 439 | ||||||||
Expiration of options | 4 | (4) | |||||||||
TOTAL TRANSACTIONS WITH SHAREHOLDERS | 760 | 435 | 121 | (1,089) | 227 | 7,238 | 7,465 | ||||
Balance ending at Jun. 30, 2022 | 111,322 | 3,014 | 755 | 9,319 | (1,687) | 197 | (7,777) | 45,142 | 8,047 | 53,189 | |
Balance beginning at Dec. 31, 2022 | 111,322 | 3,260 | 949 | 9,689 | (690) | 197 | (85,586) | 39,141 | 15,548 | 54,689 | |
Loss for the period | (8,200) | (8,200) | (1,336) | (9,536) | |||||||
Other comprehensive income loss | 139 | 139 | 167 | 306 | |||||||
TOTAL COMPREHENSIVE LOSS FOR THE PERIOD | 139 | (8,200) | (8,061) | (1,169) | (9,230) | ||||||
TRANSACTIONS WITH SHAREHOLDERS: | |||||||||||
Issuance of shares in consideration for an investment | 250 | 250 | 250 | ||||||||
Subsidiary’s share-based compensation to employees and service providers | 51 | 51 | |||||||||
Share based compensation to employees and service providers | 419 | 419 | 419 | ||||||||
Dividend declared by subsidiaries | (153) | (153) | |||||||||
Deemed issuance of shares by a subsidiary | 146 | 146 | 322 | 468 | |||||||
Deemed stock exchange listing expenses | 290 | 290 | 290 | ||||||||
Issuance of shares by Jeffs’ Brands | 100 | 100 | 188 | 288 | |||||||
Transaction with non-controlling interest by Gix Internet | (522) | (522) | (2,103) | (2,625) | |||||||
Expiration of options | 17 | (17) | |||||||||
TOTAL TRANSACTIONS WITH SHAREHOLDERS | 267 | 402 | 390 | (376) | 683 | (1,695) | (1,012) | ||||
Balance ending at Jun. 30, 2023 | $ 111,589 | $ 3,662 | $ 1,339 | $ 9,313 | $ (551) | $ 197 | $ (93,786) | $ 31,763 | $ 12,684 | $ 44,447 |
Interim Condensed Consolidate_5
Interim Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands | 6 Months Ended | |
Jun. 30, 2023 | Jun. 30, 2022 | |
Statement of cash flows [abstract] | ||
Cash flows used in operations (see Appendix A) | $ (1,839) | $ (1,485) |
Interest received | 23 | |
Dividend received | 171 | |
Interest paid | (28) | (258) |
Income tax paid | (512) | (192) |
Net cash flow used in operating activities | (2,379) | (1,741) |
Purchase of property and equipment | (21) | (20) |
Acquisitions of associates (see note 3E) | (2,993) | (1,913) |
Acquisitions of investments at fair value through profit or loss | (203) | (2,167) |
Consolidation of a subsidiary upon gain of control | 2,736 | |
Purchase of intangible assets (see note 3E and supplemental disclosure of cash flow information) | (1,681) | |
Loans to associates | (492) | |
Proceeds from sale of financial assets at fair value through profit or loss and securities of an associate | 328 | 404 |
Changes in short term deposits | 848 | |
Net cash flow used in investing activities | (4,214) | (960) |
CASH FLOWS FROM (USED IN) FINANCING ACTIVITIES: | ||
Proceeds from issuance of shares and warrants by subsidiaries, net of issuance costs | 98 | |
Cash paid to non-controlling interests (see note 3F) | (2,625) | |
Proceeds from deemed issuance of shares by a subsidiary (see note 3J) | 466 | |
Receipt of short-term loans | 1,000 | 1,000 |
Repayment of short-term loans | (111) | |
Receipt of long-term loans | 1,500 | 651 |
Repayment of long-term loans | (874) | (541) |
Repayment of related party debt | (146) | |
Dividend paid | (728) | (391) |
Principal elements of lease liability | (37) | (35) |
Net cash flow from (used in) financing activities | (1,409) | 636 |
DECREASE IN CASH AND CASH EQUIVALENTS | (8,002) | (2,065) |
BALANCE OF CASH AND CASH EQUIVALENTS AT BEGINNING OF THE PERIOD | 20,065 | 24,025 |
GAINS FROM EXCHANGE DIFFERENCES ON CASH AND CASH EQUIVALENTS | 296 | 181 |
BALANCE OF CASH AND CASH EQUIVALENTS AT END OF THE PERIOD | 12,359 | 22,141 |
NET CASH USED IN OPERATIONS: | ||
Loss for the period before taxes on income | (9,359) | (4,739) |
Adjustment in respect of: | ||
Depreciation and amortization | 1,931 | 1,749 |
Net income from changes in the fair value of assets at fair value through profit or loss | 3,978 | 813 |
Changes in fair value of warrants | (1,255) | 99 |
Changes in fair value of commitment to issue shares | 63 | |
Equity losses | 1,238 | 1,816 |
Finance expenses (income) | (543) | 145 |
Share based compensation to employees and service providers | 470 | 631 |
Gain from initial recognition of assets and liabilities upon consolidation of Gix Internet | (2,300) | |
Gain from sales of investments | (68) | |
Deemed stock exchange listing expenses (note 3J) | 290 | |
Interest received | (23) | |
Dividend received | (171) | |
Interest paid | 28 | 258 |
Income tax paid | 512 | 192 |
CHANGES IN OPERATING ASSET AND LIABILITY ITEMS: | ||
Decrease (Increase) in trade accounts receivable | 2,596 | (2,767) |
Decrease in other current assets | 814 | 30 |
Increase (Decrease) in trade accounts payable | (1,978) | 370 |
Increase (Decrease) in accrued compensation expenses | (106) | 18 |
Increase in accrued expenses and other current liabilities | 301 | 2,585 |
Decrease in deferred offering costs | 418 | |
Increase in inventory | (756) | (604) |
CASH FLOWS USED IN OPERATIONS | (1,839) | (1,485) |
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION: | ||
Income receivable from sale of shares (note 3C) | 5,774 | |
Non-cash investment in Metagramm (note 3P) | 250 | |
Non-cash investment in Polyrizon (note 3G) | 60 | |
Non-cash investment in SciSparc (note 3E and note 3I) | 325 | |
Non-cash investment in Hydreight Technologies (note 3I) | 141 | |
Decrease in investment in SciSparc due to the Amendment of the Buffalo Agreement (note 3I) | (937) | |
Consideration payable to the seller of Fort (note 3E) | 349 | |
Consideration payable to the seller of SciSparc Nutraceuticals (note 3E) | 41 | |
Right of use assets obtained in exchange for lease liabilities | 33 | 185 |
Conversion of Polyrizon SAFEs into shares (note 3G) | 314 | |
Decrease in loan balance due to modification of terms | 243 | |
Unpaid deferred offering costs included in other current liabilities | 497 | |
Non-cash investment in Laminera | 400 | |
Non-cash investment in Clearmind | $ 500 |
General
General | 6 Months Ended |
Jun. 30, 2023 | |
General [Abstract] | |
GENERAL | NOTE 1 - GENERAL A. Medigus Ltd. (the “Company” or “Medigus”) was incorporated in Israel on December 9, 1999. The Company’s registered office and principal place of business are located in Israel. The address of its registered office is Hanehoshet 10, 4th Floor, Tel-Aviv POB 6971072, Israel. The Company, together with its subsidiaries and associates, operate in the technology sector, focusing on medical-related devices and products (through its associate Polyrizon), on internet related activities (through its subsidiaries Eventer and Gix Internet), on e-commerce (through its subsidiary Jeffs’ Brands), on safety systems for commercial drones (through its associate Parazero), on energy efficiency technology (through its associate Laminera) and on the electric vehicle sector (through its subsidiary Fuel Doctor). Additionally, through its corporate, the Company is engaged in the licensing of intellectual property relating to its legacy product, the Medigus Ultrasonic Surgical Endostapler (“MUSE”), to Golden Grand Medical Instruments Ltd., a China based medical services provider, and in the investment of its excess cash resources, primarily in equity securities. “Group” - the Company together with, Jeffs’ Brands Ltd., Fuel Doctor Holdings Inc., GERD IP, Inc., Eventer Technologies Ltd. and Gix Internet Ltd. “Subsidiaries” - entities under the control of the Company. These interim condensed consolidated financial statements were approved on September 28, 2023. Odysight.ai Inc. As of December 31, 2022, the Company held 27.02% of the issued and outstanding share capital of Odysight.ai Inc., formerly known as ScoutCam Inc. (“Odysight.ai”). On March 21, 2023, Odysight.ai completed a capital raising transaction which diluted the Company’s holdings in Odysight.ai to 18.45%. On May 17, 2023, the Company signed an agreement to sell all of its shares in Odysight.ai. The sale was completed on June 1, 2023, and as of that date the Company no longer holds any shares of Odysight.ai. For additional information, see note 3C. GERD IP, Inc. As of June 30, 2023, the Company holds 90% of the issued and outstanding share capital of GERD IP, Inc. (“GERD IP”). For additional information, see note 3O. Eventer Technologies Ltd. As of June 30, 2023, the Company holds 46.21% of the issued and outstanding share capital of Eventer Technologies Ltd. (“Eventer”). For additional information, see note 3D. Gix Internet Ltd. On February 28, 2022, the Company purchased additional shares of Gix Internet Ltd. (“Gix Internet”) and the Company’s holdings interests in Gix Internet increased to 38.03%, which resulted in gain of control in Gix Internet. Accordingly, as of this date the Company started to consolidate Gix Internet. As of June 30, 2023, the Company holds 42.25% of the issued and outstanding share capital of Gix Internet. For additional information, see note 3F. Charging Robotics Ltd. and Fuel Doctor Holdings Inc. As of December 31, 2022, the Company’s activity in the electric vehicle and wireless charging sector was conducted through its wholly owned subsidiary, Charging Robotics Ltd. (“Charging Robotics”). On March 28, 2023 (the “Closing”), the Company signed a security exchange agreement with Fuel Doctor Holdings Inc. (“Fuel Doctor”) to sell all its shares in Charging Robotics to Fuel Doctor. As part of the exchange agreement, Fuel Doctor acquired all of the issued and outstanding shares of Charging Robotics, on a fully diluted basis and as a result Charging Robotics became a wholly owned subsidiary of Fuel Doctor. In exchange for all of its shares in Charging Robotics, the Company received such number of newly issues shares of Fuel Doctor’s common stock equal to 76.25% of the total number of shares of Fuel Doctor’s common stock issued and outstanding as of the Closing on a fully diluted basis. The share exchange was accounted for as a reverse acquisition where Fuel Doctor was identified as the accounting acquirer. The financial statements of Fuel Doctor are consolidated in these financial statements from the Closing date. As of June 30, 2023, the Company holds 67% of the issued and outstanding common stock of Fuel Doctor. For additional information, see notes 3H and 3J. Jeffs’ Brands Ltd. As of June 30,2023, the Company holds 34.87% of the issued and outstanding share capital of Jeffs’ Brands Ltd. (Jeffs’ Brands). For additional information, see note 3E. Interests in other entities As of June 30, 2023, the Company also holds 40.35% in Parazero Technologies Ltd. (“Parazero”) (see note 3K), 40.22% in Polyrizon Ltd. (“Polyrizon”) (see note 3G), 19.7% in Laminera Flow Optimization Ltd. (“Laminera”) (see note 3L), 4.76% in Elbit Imaging Ltd. (“Elbit Imaging”), 3.79% in Automax Ltd. (“Automax”), 2.64% in Clearmind Medicine, Inc. (“Clearmind”) (see note 3M), 0.86% in SciSparc Ltd. (“SciSparc”) (see note 3I), 2.35% in Safee Cyber Technologies Ltd. (“Safee”) (see note 3N), 1.41% in Maris-Tech Ltd. (“Maris”), 0.97% in Colugo Systems Ltd. (“Colugo”), 0.47% in Safe Foods, Inc. ( “SAFO”), 0.67% in Tondo Smart Ltd. (“Tondo”), 1.49% in Bubbles Intergroup Ltd. (“Bubbles”), 4.99% in A.I. Systems Ltd.(“A.I.”) and 19.99% in Metagramm Software Ltd (“Metagramm”) (see note 3P). B. As of the approval date of these interim condensed consolidated financial statements, the Company has cash and cash equivalents in the amount of USD 6.2 million. The Company anticipates such cash and cash equivalents will provide sufficient liquidity for more than a twelve-month period from the date of these financial statements. However, since inception, the Company’s activities have been funded mainly by its shareholders. Furthermore, in the recent years the Company has suffered recurring losses from operations, negative cash flows from operating activities, and has an accumulated deficit as of June 30, 2023. As such, the Company’s ability to continue operating may be dependent on several factors, amongst which is its ability to raise sufficient additional funding, which funding may not necessarily be available to the Company, obtained on terms favorable to the Company, or provide the Company with sufficient funds to meet its objectives. |
Basis for Preparation of the In
Basis for Preparation of the Interim Condensed Consolidated Financial Statements | 6 Months Ended |
Jun. 30, 2023 | |
Basis for Preparation of the Interim Condensed Consolidated Financial Statements [Abstract] | |
BASIS FOR PREPARATION OF THE INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS | NOTE 2 - BASIS FOR PREPARATION OF THE INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS A. The Group’s interim condensed consolidated financial information as of June 30, 2023, and for the six-month period ended on that date (hereinafter - “The Interim Financial Information”) have been prepared in accordance with the guidance of IAS 34 ‘Interim Financial Reporting’. The Interim Financial Information has been prepared on the basis of the accounting policies adopted in the Group’s audited consolidated financial statements for the year ended December 31, 2022 (“Annual Financial Statements”), which were prepared in accordance with International Financial Reporting Standards which are standards and interpretations thereto issued by the International Accounting Standard Board (hereinafter “IFRS”). This Interim Financial Information should be read in conjunction with the Annual Financial Statements and notes thereto issued on May 3, 2023. The Interim Financial Information is unaudited, does not constitute statutory accounts and does not contain all the information and footnotes required by accounting principles generally accepted under IFRS for annual financial statements. B. Estimates: The preparation of the interim condensed consolidated financial statements requires the Group’s management to exercise judgment and also requires use of accounting estimates and assumptions that affect the application of the Group’s accounting policies and the reported amounts of assets, liabilities, revenues and expenses. Actual results could differ from those estimates. In the preparation of these interim condensed consolidated financial statements, the significant judgments exercised by management in the application of the Group’s accounting policies and the uncertainty involved in the key sources of those estimates were identical to the ones used in the Group’s 2022 Annual Financial Statements. C. Implementation of amendments to existing accounting standards: Amendments to IAS 8 Accounting Policies, Changes in Accounting Estimates and Errors - Definition of Accounting Estimates The amendments replace the definition of a change in accounting estimates with a definition of accounting estimates. Under the new definition, accounting estimates are “monetary amounts in financial statements that are subject to measurement uncertainty”. The definition of a change in accounting estimates was deleted. However, the IASB retained the concept of changes in accounting estimates in the Standard with the following clarifications: ● A change in accounting estimate that results from new information or new developments is not the correction of an error ● The effects of a change in an input or a measurement technique used to develop an accounting estimate are changes in accounting estimates if they do not result from the correction of prior period errors The amendments are effective for annual periods beginning on or after 1 January 2023 to changes in accounting policies and changes in accounting estimates that occur on or after the beginning of that period. Amendments to IAS 12 Income Taxes - Deferred Tax related to Assets and Liabilities arising from a Single Transaction The amendments introduce a further exception from the initial recognition exemption. Under the amendments, an entity does not apply the initial recognition exemption for transactions that give rise to equal taxable and deductible temporary differences. Depending on the applicable tax law, equal taxable and deductible temporary differences may arise on initial recognition of an asset and liability in a transaction that is not a business combination and affects neither accounting nor taxable profit. Following the amendments to IAS 12, an entity is required to recognize the related deferred tax asset and liability, with the recognition of any deferred tax asset being subject to the recoverability criteria in IAS 12. The amendments apply to transactions that occur on or after the beginning of the earliest comparative period presented. The amendments are effective for annual reporting periods beginning on or after 1 January 2023. D. Seasonal fluctuations: In connection with the Company’s subsidiary, Eventer, there is an increase in events scheduled during the holiday season in Israel, which typically occurs in September and October, and which corresponds to an increase in ticket sales. In connection with the Company’s subsidiary, Jeffs’ Brands, the fourth quarter of each fiscal year typically yields significant activity due to the holiday season. As a result, revenue generally declines and loss from operations generally increases in the first quarter sequentially from the fourth quarter of the previous year. In connection with the Company’s subsidiary, Gix Internet, there is a seasonal trend in which the fourth quarter is characterized by higher activity and the average first quarter is characterized by lower activity. As a rule, advertising campaigns take place throughout the year in high intensity, and therefore the seasonality trend is not significant in the field of activity. This seasonality is due, among other things, to changes in the large advertising budgets, usually towards the end of each quarter and towards the end of each year. In addition, the last quarter of the year includes many leading events, causing an increase in online advertising budgets. |
Interest in Other Entities
Interest in Other Entities | 6 Months Ended |
Jun. 30, 2023 | |
Interest in Other Entities [Abstract] | |
INTEREST IN OTHER ENTITIES | NOTE 3 - INTEREST IN OTHER ENTITIES A. Investments in subsidiaries 1. Additional information about subsidiaries held by the Company General information Main place of Ownership rights held by the Company % Ownership rights held by non- controlling interests % June 30, 2023 Jeffs’ Brands Israel 34.87 65.13 Eventer Israel 46.21 53.79 Fuel Doctor USA 67 33 GERD IP USA 90 10 Gix Internet Israel 42.25 57.75 Main place of Ownership rights held by the Company % Ownership rights held by non- controlling interests % December 31, 2022 Jeffs’ Brands Israel 35.94 64.06 Eventer Israel 46.21 53.79 Charging Robotics Israel 100 - GERD IP USA 90 10 Gix Internet Israel 42.25 57.75 2. Summarized financial information of subsidiaries Eventer Summarized statement of financial position: June 30, December 31, USD in thousands (*) Current assets 2,044 1,829 Non-current assets 1,315 1,379 Current liabilities 3,234 2,766 Non-current liabilities - 476 Equity (Deficit) 125 (34 ) (*) Translated according to the exchange rate at the date of each statement of financial position. Summarized statement of comprehensive income: Six months ended June 30, 2023 2022 USD in thousands (**) Revenues 1,498 1,472 Net profit (loss) for the period 111 (587 ) Summarized statement of cash flows: Six months ended June 30, 2023 2022 USD in thousands (**) Cash flow from operating activities 199 1,235 Cash flow used in investing activities (6 ) (6 ) Cash flow used in financing activities - (146 ) Losses from exchange differences on cash and cash equivalents (79 ) (288 ) Net increase in cash and cash equivalents 114 795 (**) Translated according to the average exchange rates for each period. Jeffs’ Brands Summarized statement of financial position: June 30, December 31, USD in thousands Current assets 5,457 11,033 Non-current assets 9,622 4,743 Current liabilities 5,239 5,133 Non-current liabilities 88 98 Equity 9,752 10,545 Summarized statement of comprehensive income: Six months ended June 30, 2023 2022 USD in thousands Revenues 3,871 2,343 Net loss for the period (1,079 ) (1,526 ) Six months ended June 30, 2023 2022 USD in thousands Cash flow used in operating activities (749 ) (1,054 ) Cash flow used in investing activities (4,998 ) (3 ) Cash flow from (used in) financing activities (119 ) 731 Net decrease in cash and cash equivalents (5,866 ) (326 ) Gix Internet Summarized statement of financial position: June 30, December 31, USD in thousands (*) Current assets 22,701 26,481 Non-current assets 15,367 16,549 Current liabilities 27,692 29,529 Non-current liabilities 4,069 4,127 Equity 6,307 9,374 Equity attributable to Gix Internet shareholders 2,517 4,804 Non-controlling interests 3,790 4,570 (*) Translated according to the exchange rate at the date of each statement of financial position. Summarized statement of comprehensive income: Six months March 1, USD in thousands (**) Revenues 48,016 31,144 Net profit (loss) for the period (122 ) 164 Summarized statement of cash flows: Six months March 1, USD in thousands (**) Cash flow from operating activities 993 989 Cash flow used in investing activities (8 ) (9 ) Cash flow from (used in) financing activities (1,851 ) 1,661 Gain from exchange differences on cash and cash equivalents 109 51 Net increase (decrease) in cash and cash equivalents (757 ) 2,692 (**) translated at average exchange rates for each period. 3. Information related to non-controlling interests Balance of non-controlling interests: June 30, December 31, USD in thousands Eventer 860 721 Jeffs’ Brands 6,727 7,199 Charging Robotics - 91 Gix Internet 4,724 7,480 GERD IP 57 57 Fuel Doctor 316 - 12,684 15,548 Profit (Loss) attributed to non-controlling interests: Six months ended June 30, 2023 2022 USD in thousands Eventer 88 (307 ) Jeffs’ Brands (661 ) (793 ) Gix Internet (668 ) (65 ) GERD IP - 7 Fuel Doctor (95 ) - (1,336 ) (1,158 ) B. Investments accounted for using the equity method 1. This table summarizes the total investments accounted for using the equity method: June 30, December 31, USD in thousands Odysight.ai (note 3C) - 9,375 Parazero (note 3K) 592 976 Laminera (note 3L) 1,142 1,176 Polyrizon (note 3G) 643 214 SciSparc Nutraceuticals (note 3E) 2,944 - Revoltz (note 3H) 133 151 5,454 11,892 2. This table summarizes the total equity losses from investments accounted for using the equity method: Six months ended June 30, 2023 2022 USD in thousands Odysight.ai (note 3C) 655 1,073 Gix Internet (note 3F) - 215 Parazero (note 3K) 384 295 Laminera (note 3L) 34 81 Polyrizon (note 3G) 65 159 Elbit Imaging - 78 SciSparc Nutraceuticals (note 3E) 89 - Revoltz (note 3H) 11 9 1,238 1,910 3. This table summarize the Company’s rights in share capital and voting rights: Main place of business Company rights in share June 30, 2023 Parazero Israel 40.35 % Laminera Israel 19.70 % Polyrizon Israel 40.22 % Revoltz Israel 19.90 % SciSparc Nutraceuticals USA 49.9 % December 31, 2022 Parazero Israel 40.35 % Laminera Israel 19.70 % Polyrizon Israel 37.03 % Revoltz Israel 19.90 % Odysight.ai Israel 27.02 % Fuel Doctor Israel 28.63 % As of December 31, 2022, the Company held 27.02% of the outstanding common stock of Odysight.ai. On March 21, 2023, Odysight.ai completed a private placement to existing stockholders, of 3,294,117 units, at a purchase price of USD 4.25 per unit, with each unit consisting of one share of Odysight.ai’s common stock and one warrant to purchase one share of Odysight.ai’s common stock at an exercise price of USD 5.50 per share. The Company did not participate in the private placement. Following the private placement, the Company’s holdings in Odysight.ai were diluted to 18.45% and the remaining holding was accounted for as investment at fair value through profit or loss (FVTPL). As a result of the transition, the Company recognized a loss of USD 2,946 thousand. On May 17, 2023, the Company signed a stock transfer agreement to sell its entire holdings in Odysight.ai for total proceeds of approximately USD 5.7 million. Activity in investment account: January 1, 2023- USD Investment as of January 1, 2023 9,375 Loss for the period (655 ) Balance as of March 21, 2023 8,720 Loss as a result of transition to FVTPL (2,946 ) Fair value of the investment as of March 21, 2023 5,774 D. Eventer General On October 14, 2020, the Company signed a share purchase agreement and a revolving loan agreement with Eventer, a technology company engaged in the development of unique tools for automatic creation, management, promotion, and billing of events and ticketing sales. Pursuant to the share purchase agreement, the Company invested USD 750 thousand. The share purchase agreement provides that the Company will invest an additional investment of USD 250 thousand in a second tranche (“Earn-out), subject to Eventer achieving certain post-closing EBITDA based milestones during the fiscal years 2021 through 2023, or the “Milestones”. As of June 30, 2023, the Milestones have not been achieved and the fair value of the Earn-out was determined to be immaterial. Additionally, on October 14, 2020, the Company entered into an Exchange Agreement with Eventer’s shareholders, pursuant to which, during the period commencing on the second anniversary of the Exchange Agreement and ending fifty-four (54) months following the date of the Exchange Agreement, Eventer’s shareholders may elect to exchange all of their Eventer shares for ordinary shares of the Company. The Company treated the Exchange Agreement at the date of the business combination from accounting perspective as recognition of noncontrolling interests, in addition to the recognition of a liability in respect of a derivative (exchange options) which will be measured at fair value at each cut-off date and will be revalued. The changes in the fair value at each cut-off date will be recorded as a financial income/expense. The Company concluded that the fair value of this derivative is immaterial. As of June 30, 2023, The Company holds 46.21% of Eventer’s outstanding common stock. Loan agreement with Safee Cyber Technologies Inc. On August 1, 2022, the Company and Eventer signed a loan agreement with Safee Cyber Technologies Inc. (“Safee”). For more details about the loan agreement, see note 4D to the Annual Financial Statements. Contingent liabilities On December 14, 2022, a motion to certify a class action suit was filed against Eventer and two of its directors, alleging the violation of the provisions of the Prohibition of Discrimination in Products, Services, and Entry into Places of Entertainment and Public Places Law. The plaintiff claims that Eventer enables the allocation of different kinds of tickets to different groups (such as women, children etc.), thereby allowing structured discrimination. According to the opinion of Eventer’s legal counsel, the chances of the class action to be rejected are more likely than not both against Eventer and its directors. A hearing is scheduled for January 3, 2024. Agreement with Screenz Cross Media Ltd. On February 4, 2021, Eventer signed an addendum to the agreement with Screenz Cross Media Ltd. (a company indirectly controlled and managed by Eli Uzan who serves as Eventer’s Director) (hereafter “Screenz”). The agreement was signed during November 2020 for the purpose of collaborating in the field of virtual conferences. According to the provisions of the addendum to the agreement, Eventer will receive an exclusive license for using the broadcasting system of Screenz with respect to the field of virtual conferences and development services, and in exchange will pay Screenz an amount of USD 1,500 thousand (approximately NIS 4,280 thousand) over a period of eight months, as well as 8% from the revenues earned from using the broadcasting system in the field of virtual conferences. In December 2021, March 2022 and December 2022, several amendments were signed between Eventer and Screenz in order to modify the terms of the loan. Following the last amendment in December 2022, Eventer repaid its debt to Screenz by assigning to Screenz the remaining unutilized advertising rights Eventer had purchased from Keshet. The prepaid expense balance in respect of these advertising rights in the books of Eventer as of the repayment date, which approximates the advertising rights’ fair value, was USD 660 thousand. The debt balance as of the date of the amendment was USD 1,062 thousand (NIS 3,862 thousand). The difference between the debt balance and the advertising rights of USD 402 thousand was recorded as a capital contribution from Screenz to Eventer. It was also determined that Screenz will have the first right to receive any money received from Eventer and resulting from a digital ticketing platform for interactive virtual events up to a total amount of USD 480 thousand. As of June 30, 2023, the Company concluded that the fair value of this commitment is immaterial given the uncertainty of generating revenues by Eventer from interactive virtual events. Share based compensation grants 1. On March 30, 2021, Eventer granted its CEO 29,944 options to purchase 29,944 shares at an exercise price of 0.001 NIS per share. The options shall vest over a period of three years. The fair value of this grant was approximately NIS 1,668 thousand (USD 473 thousand). For the six months ended June 30, 2023, and 2022, approximately NIS 91 thousand (USD 25 thousand) and NIS 254 thousand (USD 78 thousand), respectively, were recognized and recorded as expenses. 2. On March 30, 2021, Eventer granted Round Robin Ltd., which is one of the founding partners of Eventer, 29,944 options to purchase 29,944 shares at exercise price of 0.001 NIS per share. The options shall vest over a period of three years. The fair value of this grant was approximately NIS 1,668 thousand (USD 473 thousand). For the six months ended June 30, 2023, and 2022, approximately NIS 91 thousand (USD 25 thousand) and NIS 254 thousand (USD 78 thousand), respectively, were recognized and recorded as expenses. E. Jeffs’ Brands General Jeffs’ Brands was incorporated in Israel on March 7, 2021. As of the date of issuance of these financial statements, Jeffs’ Brands has five wholly owned subsidiaries - Smart Repair Pro (“Smart Pro”), Top Rank Ltd. (“Top Rank”), Jeffs’ Brands Holdings Inc. (“Jeffs’ Brands Holdings”), Fort Products Ltd. (“Fort”) and Fort Products LLC (“Fort US”). Jeffs’ Brands and its subsidiaries are engaged in the acquisition, improvement and operation of virtual stores (the “Brands”) mainly on the Amazon.com (“Amazon”) website. As of June 30, 2023, the Company holds 34.87% of the issued and outstanding share capital of Jeffs’ Brands. Wellution Agreement On February 23, 2023, Jeffs’ Brands and Jeffs’ Brands Holdings, entered into a stock purchase agreement (the “Wellution Agreement”), with SciSparc Ltd. (“SciSparc”), pursuant to which, on March 22, 2022, Jeffs’ Brands Holdings acquired from SciSparc 57 shares of common stock of SciSparc Nutraceuticals Inc. (“SciSparc Nutraceuticals”), a wholly-owned subsidiary of SciSparc that owns and operates Wellution, an Amazon food supplements and cosmetics brand, representing approximately 49% of the issued and outstanding common stock of SciSparc Nutraceuticals, for approximately USD 3 million in cash (the “Wellution Transaction”). Also pursuant to the Wellution Agreement, on March 22, 2023, Jeffs’ Brands entered into a consulting agreement with SciSparc Nutraceuticals (the “SciSparc Consulting Agreement”), pursuant to which Jeffs’ Brands will provide management services to SciSparc Nutraceuticals for the Wellution brand for a monthly fee of USD 20 thousand. In addition, Jeffs’ Brands also received a one-time signing bonus in the amount of USD 51 thousand. The SciSparc Consulting Agreement is for an undefined period of time and may be terminated by either party with 30 days advance notice. Jeffs’ Brands concluded that substantially all of the fair value of the gross assets acquired is concentrated in a single identifiable asset, the Wellution brand. Thus, the Wellution Transaction does not qualify as a business as defined in IFRS 3, “Business Combinations”. The investment in SciSparc Nutraceuticals was accounted for using the equity method. The changes in the investment in SciSparc Nutraceuticals for the six months period ended June 30, 2023, were as follows: February 23, 2023 – USD Balance as of January 1, 2023 - Purchase on February 23, 2023 3,033 Loss for the period (89 ) Balance as of June 30, 2023 2,944 Also pursuant to the Wellution Agreement, in connection with the closing of the Wellution Transaction, on March 22, 2023, Jeffs’ Brands issued 247,415 of its Ordinary Shares to SciSparc and SciSparc issued 360,297 of its Ordinary Shares to Jeffs’ Brands in a share exchange (collectively, the “Exchange Shares”), representing 2.97% and 4.99%, respectively, of Jeffs’ Brands’ and SciSparc’s issued and outstanding ordinary shares. The number of Exchange Shares acquired by each company was calculated by dividing USD 288,238 by the average closing price of the relevant company’s shares on the Nasdaq Capital Market for the 30 consecutive trading days ending on the third trading day immediately prior to the closing. The investment in SciSparc was accounted for as a financial asset measured at fair value through profit or loss. Fort share purchase agreement On March 2, 2023, Jeffs’ Brands entered into a share purchase agreement (the “Fort SPA”), with the holders (the “Sellers”), of all of the issued and outstanding share capital of Fort, a company incorporated under the laws of England and Wales and engaged in the sale of pest control products primarily through Amazon.uk, pursuant to which, on March 9, 2023, Jeffs’ Brands acquired all of the issued and outstanding share capital of Fort, for approximately £2,000 thousand (approximately USD 2,400 thousand) in cash (the “Fort Acquisition”). Also, in connection with the Fort Acquisition, on March 9, 2023, Jeffs’ Brands and Fort entered into settlement agreements with all of Fort’s employees, including the Sellers, by which such employees’ employment with Fort will terminate three months following March 9, 2023. Also, in connection with the closing of the Fort Acquisition, on March 9, 2023, Jeffs’ Brands and the Sellers entered into a consulting agreement, pursuant to which the Sellers will provide Jeffs’ Brands with consultancy services for a period of three months for a monthly fee of approximately USD 3 thousand. On September 20, 2023, Jeffs’ Brands and the Sellers entered into a new consulting agreement for indefinite period at a monthly fee of approximately USD 4.5 thousand effective as of June 1, 2023. Jeffs’ Brands concluded that substantially all of the fair value of the gross assets acquired is concentrated in a single identifiable asset, the Fort brand. Thus, the Fort Acquisition does not qualify as a business as defined in IFRS 3, “Business Combinations”. Initial Public Offering On August 30, 2022, Jeffs’ Brands completed its initial public offering (“IPO”) on the Nasdaq. In connection with the IPO, Jeffs’ Brands sold 3,717,473 units at a public offering price of USD 4.16 per unit, with each unit consisting of one ordinary share, no par value per share (“Ordinary Share”), and one warrant (“IPO Warrant”), to purchase one Ordinary Share, at an exercise price of USD 4.04 per Ordinary Share. Additionally, Jeffs’ Brands issued warrants to the underwriter to purchase up to 185,873 ordinary shares at an exercise price of USD 5.20 per Ordinary Share (“Underwriter’s Warrants”). The underwriter partially exercised its right to purchase an additional 425,912 warrants for total consideration of USD 4 thousand. Jeffs’ Brands received total net proceeds of USD 13.4 million after deducting issuance costs of USD 2.1 million. Following the IPO completion, the Company’s holdings in Jeffs’ Brands decreased to 35.94% of the issued and outstanding share capital of Jeffs’ Brands. On September 7, 2022, Jeffs’ Brands’ volume weighted average stock price was less than the exercise floor of USD 4.04 for the IPO Warrants. Accordingly, and based on the contractual terms of the IPO Warrants, effective after the closing of trading on November 28, 2022 (the 90 th Additionally, Additional Warrants were issued to each qualified buyer who continued to hold at least 120,192 IPO Warrants as of November 28, 2022 (“Additional Warrants”). Accordingly, Jeffs’ Brands issued Additional Warrants to purchase 2,824,525 Ordinary Shares. Each Additional Warrant has substantially the same terms as the As-Adjusted IPO Warrant; provided, however, that the term of each Additional Warrant will be five (5) years from the issuance date and such Additional Warrant will not be listed on any securities exchange. In addition, as long as the Additional Warrants are outstanding, each Additional Warrants holder will receive semi-annual payments based on the Jeffs’ Brands consolidated revenues, dependent on the amount of the Additional Warrants outstanding. As of June 30, 2023, the payment will be equal to approximately 2.18% of Jeffs’ Brands consolidated revenues for the six months ended June 30, 2023. The IPO Warrants and the Additional Warrants were accounted for as derivative liabilities measured at fair value through profit or loss (see note 4). Amazon Loans On May 9, 2022, Smart Pro entered into a loan agreement with Amazon. Pursuant to the loan agreement, Pro received from Amazon.com an aggregate amount of USD 153 thousand. The loan matures within 12 months and bears an annual interest at a rate of 9.99% per year. In order to secure the loan, Pro pledged its financial balances on its Amazon account on Amazon.com and its inventories held in Amazon’s warehouses, in favor of Amazon. In March 2023, the loan was fully repaid. Consultant agreement with Pure Capital On October 26, 2022, Jeffs’ Brands and L.I.A Pure Capital Ltd. (“Pure Capital”), a related party of Jeffs’ Brands, entered into a consulting agreement, pursuant to which Pure Capital will provide consulting services to Jeffs’ Brands for a monthly fee of NIS 57.5 thousand (approximately USD 16.5 thousand). Jeffs’ Brands paid Pure Capital a one-time signing bonus in the amount of NIS 425 thousand (approximately USD 121 thousand) for their services to Jeffs’ Brands from the day of Jeffs’ Brands inception until the closing of the IPO. As part of the consulting agreement, Pure Capital is also entitled to the following payments: (i) an amount equal to 7% of the gross proceeds paid to Jeffs’ Brands in connection with any exercise of warrants, whether or not currently outstanding; and (ii) 8% of the total consideration paid in connection with any purchase of a new brand, businesses, or similar events initiated or assisted by Pure Capital and approved by the Chief Executive Officer and Chairman of the Board based on agreement with Pure Capital. The consulting agreement is for an undefined period of time and may be terminated after 3 years from October 26, 2022, by either party upon 30 days advance notice. In March 2023, Jeffs’ Brands paid Pure Capital USD 352 thousand in accordance with the terms of the consulting agreement. The consultancy fees were paid in consideration with the investments in Fort and SciSparc Nutraceuticals. Additionally, on October 26, 2022, Jeffs’ Brands and Pure NJ Logistics LLC, a company owned by Pure Capital and a director of Jeffs’ Brands, entered into a warehouse lease agreement for a warehouse located in New Jersey, USA. F. Gix Internet General As of December 31, 2022, the Company held 42.25% of the issued and outstanding share capital of Gix Internet. In addition, the Company held 3,171,159 tradable warrants. As of December 31, 2022, Gix Internet held 76% of the issued and outstanding share capital of ViewBix Inc. ViewBix Inc held 100% of the issued and outstanding share capital of Gix Media. Gix Media held 70% of the issued and outstanding share capital of Cortex. On September 14, 2022, Gix Media declared a dividend in the amount of USD 1,000 thousand. The amount, net of tax, was distributed partially as of December 31, 2022. The remaining amount was distributed by Gix Media in January 2023. On December 25, 2022, Cortex declared a dividend in the total amount of USD 445 thousand to the non-controlling interests. The amount was distributed by Cortex to non-controlling interests in two payments of USD 219 thousand and USD 226 thousand in February and March 2023, respectively. On June 29, 2023, Cortex declared and distributed a dividend in the total amount of USD 153 thousand to the non-controlling interests. On January 23, 2023, Gix Media acquired an additional 10% of the share capital of Cortex, increasing its holdings to 80% in consideration for USD 2,625 thousand (the “Subsequent Purchase”). The Subsequent Purchase was financed by Gix Media’s existing cash balances and by a long-term bank loan received on January 17, 2023, in the amount of USD 1,500 thousand. The Subsequent Purchase was recorded as a transaction with non-controlling interests in the Group’s statement of changes in shareholders equity for the six-month period ended June 30, 2023. Loans Short term loans: June 30, December 31, USD in thousands Short term bank loans 5,973 5,025 Current maturities of long-term loans 1,879 1,500 7,852 6,525 Long term loans: June 30, December 31, USD in thousands Long term bank loans 3,128 2,881 3,128 2,881 On October 13, 2021, Gix Media entered into a loan agreement with Bank Leumi Le-Israel (“Bank Leumi”) to provide a line of credit in an aggregate amount of up to USD 3.5 million and a long-term loan in an aggregate amount of up to USD 6 million. Additionally, Gix Internet also signed on a loan agreement with Bank Leumi in an aggregate amount of up to NIS 3 million. The main points of the agreement with Bank Leumi include: ● NIS 3 million loan to Gix Internet for 48 months period. The loan shall bear interest at rate of prime plus 2.92% annually. The loan was classified as long-term loan. ● USD 6 million loan to Gix Media for 48 months period. The loan shall bear interest at rate of LIBOR plus 4.12% annually. The loan was classified as long-term loan. ● Credit line to Gix Media in an aggregate amount of up to USD 3.5 million to be utilized for a period of up to 48 months. The amounts that will be drawn from the credit line will bear interest of LIBOR plus 3.2% annually. The credit line was classified as short-term loan. On September 21, 2022, Cortex and Bank Leumi Le Israel Ltd (“Leumi”) entered into an addendum to an existing loan agreement between the parties, dated August 15, 2020. As part of the addendum to the loan agreement, Leumi provided Cortex with a monthly renewable credit line of USD 1,500 thousand (the “Cortex Credit Line”). The Cortex Credit Line is determined every month at the level of 70% of Cortex’s customers’ balance. The amounts that are drawn from the Cortex Credit Line bear an annual interest of SOFR + 3.52% (Overnight Financing Rate Secured, guaranteed daily interest as determined in accordance with the Federal Bank in New York). On April 27, 2023, Leumi increased the Cortex Credit Line by USD 1,000 thousand, which was fully withdrawn by Cortex as of June 30, 2023. Loan agreement between the Company and Gix Internet On October 13, 2021, the Company entered into a loan agreement with Gix Internet. Pursuant to the loan agreement, Gix Internet received an aggregate amount of USD 1,240 thousand (NIS 4,000 thousand) from the Company. The loan bears interest at a rate equivalent to the minimal interest rate recognized and attributed by the Israel Tax Authority (3.23% in 2022). According to the agreement, the loan will be repaid in full, together with the accrued interest, in one (1) instalment upon the earliest of: (i) the closing of a rights offering by Gix Internet for an aggregate amount of at least NIS 12,000 thousand (approximately USD 3,858 thousand); or (ii) June 30, 2022. Upon consolidation of Gix Internet as of February 28, 2022, as further described above, the loan is eliminated in consolidation. The Company concluded the stated interest is materially lower than its market price. The loan was initially measured at fair value in accordance with IFRS 9, “Financial Instruments”. Accordingly, the difference between the fair value and face value of the loan attributable to the Company was recorded as a capital reserve. The difference between the fair value and face value of the loan attributable to Gix Internet was recorded as a deemed contribution by the Company to Gix Internet. On November 2, 2022, the Company received a total of NIS 1 million as repayment of the loan and the accrued interest up to that date. On August 25, 2022, the Company and Gix Internet signed an addendum to the loan agreement, effective as of July 1, 2022. The addendum changes the repayment terms of the loan in the amount of NIS 3 million to June 30, 2023. In addition, the Company will be entitled to request the conversion of all or part of the balance of the extended loan in exchange for Gix Internet’s shares The Company concluded the modified loan terms (“Modified Loan”), represent a substantial modification in accordance with IFRS 9 and is accounted for as an extinguishment of the original financial liability and the recognition of a new financial liability. Accordingly, the difference between the fair value and face value of the loan attributable to the Company was recorded as a deemed contribution by the Company to Gix Internet. Similarly, the difference between the fair value and face value of the loan attributable to the non-controlling interests was recorded as a deemed contribution by the non-controlling interests to Gix Internet. On August 30, 2023, the Company and Gix Internet signed an addendum to the loan agreement, effective as of June 30, 2023. Pursuant to the addendum, the loan repayment will be postponed until January 1, 2024. Stock Incentive Plan On March 2, 2023, the Board of Viewbix approved the adoption of the 2023 stock incentive plan (the “2023 Plan”). The 2023 Plan permits the issuance of up to (i) 2,500,000 shares of Common Stock, plus (ii) an annual increase equal to the lesser of (A) 5% of Viewbix’s outstanding capital stock on the last day of the immediately preceding calendar year; and (B) such smaller amount as determined by the Board, provided that no more than 2,500,000 shares of Common Stock may be issued upon the exercise of incentive stock options. If any outstanding awards expire, are canceled or are forfeited, the underlying shares would be available for future grants under the 2023 Plan. As of the date of approval of the financial statements, Viewbix had reserved 2,500,000 shares of Common Stock for issuance under the 2023 Plan. In connection with the adoption of the 2023 Plan, on March 7, 2023, Viewbix entered into certain intercompany reimbursement agreements with two of its subsidiaries, Viewbix Israel and Gix Media (the “Recharge Agreements”). The Recharge Agreements provide for the offer of awards under the 2023 Plan to service providers of Viewbix Israel and Gix Media (the “Affiliates”) under the 2023 Plan. Under the Recharge Agreements, the Affiliates will each bear the costs of awards granted to its service providers under the 2023 Plan and will reimburse Viewbix upon the issuance of shares of Common Stock pursuant to an award, for the costs of shares issued, but in any event not prior to the vesting of an award. The reimbursement amount shall be equal to the lower of (a) the book expense for such award as recorded on the financial statements of one of the respective Affiliates, determined and calculated according to U.S. GAAP, or any other financial reporting standard that may be applicable in the future, or (b) the fair value of the shares of Common Stock at the time of exercise of an option or at the time of vesting of an RSU, as applicable. As of June 30, 2023, 51,020 stock-based awards were granted by Viewbix under the 2023 Plan. G. Polyrizon Investment in shares and SAFE Polyrizon is a private company engaged in developing biological gels designed to protect patients against biological threats and reduce the intrusion of allergens and viruses through the upper airways and eye cavities. As of December 31, 2022, the Company held 37.03% of Polyrizon shares and the investment is accounted for using the equity method. On January 27, 2022, Polyrizon entered into a Simple Agreement for Future Equity (“SAFE”) with several investors for aggregated proceeds of USD 250 thousand, of which USD 110 thousand were invested by the Company. On May 8, 2022, Polyrizon entered into an additional SAFE with several investors for aggregated proceeds of USD 550 thousand, of which USD 203 thousand were invested by the Company. According to the SAFEs, upon completion of an IPO, the SAFE will be automatically converted into a number of ordinary shares equal to the purchase amount divided by the per unit price in the offering. If an IPO will not occur by July 31, 2023, the SAFEs will be automatically converted into such number of the most senior class of equity shares of Polyrizon then outstanding, equal to, the purchase amount, divided by the lowest price per share actually paid to Polyrizon for such most senior class of equity shares of the Company then outstanding, discounted by 20%. The SAFEs investments were accounted for as assets through profit or loss measured at fair value. As of December 31, 2022, the fair value of the SAFEs was USD 302 thousand. On June 20, 2023, the Company and other investors signed a share purchase agreement with Polyrizon in the amount of USD 450 thousand of which the Company invested USD 120 thousand in cash and USD 60 thousand in shares. As part of the share purchase agreement, the SAFEs were converted into 1,024,321 ordinary shares of Polyrizon, discounted by 20%. As of June 30, 2023, and as a result of the share purchase agreement and the SAFEs conversion, the Company’s holdings in Polyrizon increased to 40.22% of the issued and outstanding ordinary shares of Polyrizon. The changes in the investment in Polyrizon for the six months period ended June 30, 2023, were as follows: For the USD Balance as of January 1, 2023 214 Loss for the period (65 ) Additional purchase on June 20, 2023 180 Safe conversion into shares 314 Balance as of June 30, 2023 643 Investment in options In July 2020, the Company was granted with an option (the “Original Option”) to invest an additional amount of up to USD 1 million in consideration for 3,107,223 shares of Polyrizon. The Original Option is exercisable until the earlier of (i) April 23, 2023, or (ii) the consummation by Polyrizon of equity financing of at least |
Financial Instruments
Financial Instruments | 6 Months Ended |
Jun. 30, 2023 | |
Financial Instruments and Financial Risk Management [Abstract] | |
FINANCIAL INSTRUMENTS | NOTE 4 - FINANCIAL INSTRUMENTS Below is an analysis of the financial instruments carried at fair value. The different levels have been defined as follows: ● Quoted prices (unadjusted) in active markets for identical assets or liabilities (level 1). ● Inputs other than quoted prices included within level 1 that are observable for the asset or liability, either directly (that is, as prices) or indirectly (that is, derived from prices) (level 3). Financial assets A. The following table presents the level 1 and level 3 fair value financial assets - investments in shares, warrants and SAFEs as of June 30, 2023, and December 31, 2022 June 30, 2023 December 31, 2022 Level 1 Level 3 Total Level 1 Level 3 Total USD in thousands Safo shares 8 - 8 10 - 10 Maris shares 110 - 110 84 - 84 Maris warrants - 16 16 - 13 13 Tondo shares 101 - 101 97 - 97 Safee shares (note 3N) - 400 400 - 400 400 SciSparc shares (notes 3I and 3E) 233 - 233 659 - 659 Polyrizon warrants (note 3G) - 117 117 - 399 399 Polyrizon SAFEs (note 3G) - - - - 302 302 Elbit Imaging shares 578 - 578 613 - 613 Hydreight Technologies shares (note 3I) 109 - 109 - - - Clearmind warrants (note 3M) - 4 4 - 4 4 A.I Systems shares (note 3Q) 47 - 47 - - - Clearmind shares (note 3M) 90 - 90 594 - 594 Metagramm shares (note 3P) - 250 250 - - - Colugo shares - 400 400 - 400 400 Parazero SAFEs (note 3K) - 520 520 - 520 520 Bubbles shares 106 - 106 151 - 151 Automax warrants 6 - 6 9 - 9 Automax shares 341 - 341 1,114 - 1,114 Total 1,729 1,707 3,436 3,331 2,038 5,369 B. The following table presents the level 1 and level 3 fair value financial assets – loans to associates and others as of June 30, 2023, and December 31, 2022 June 30, 2023 December 31, 2022 Level 1 Level 3 Total Level 1 Level 3 Total USD in thousands Loan to Revoltz (note 3H) - 62 62 - 62 62 Loan to Polyrizon (note 3G) - 80 80 - - - Loan to A.I Systems (note 3Q) - 894 894 - 940 940 Total - 1,036 1,036 - 1,002 1,002 C. The following table presents the level 1 and level 3 fair value financial assets included in other receivables as of June 30, 2023, and December 31, 2022 June 30, 2023 December 31, 2022 Level 1 Level 3 Total Level 1 Level 3 Total USD in thousands Shares receivable (note 3I) 106 500 606 - - - Total 106 500 606 - - - D. The following table presents the Level 1 financial assets - investments in shares and warrants roll-forward during the six months ended June 30, 2023: Safo Tondo A.I Bubbles Hydreight SciSparc Maris Automax Odysight.ai Clearmind Elbit Automax Total USD in thousands Balance as of January 1, 2023 10 97 - 151 - 659 84 9 - 594 613 1,114 3,331 Purchase of securities - - 83 - 141 325 - - - - - - 549 Transfer from equity method - - - - - - - - 8,720 - - - 8,720 Net changes at fair value recognized through profit or loss (2 ) 4 (36 ) (45 ) (32 ) 320 26 (3 ) (2,946 ) (504 ) 185 (773 ) (3,806 ) Sale of securities - - - - - (1,045 ) - - (5,774 ) - (220 ) - (7,039 ) Realized loss - - - - - (26 ) - - - - - - (26 ) Balance as of June 30, 2023 8 101 47 106 109 233 110 6 - 90 578 341 1,729 (*) For more information, see note 3C. E. The following table presents the Level 3 financial assets - investments in shares, warrants and SAFEs roll-forward during the six months ended June 30, 2023: Maris Polyrizon Clearmind Safee Parazero s Polyrizon Colugo Metagramm Total USD in thousands Balance as of January 1, 2023 13 399 4 400 520 302 400 - 2,038 Purchase of securities - - - - - - - 250 250 Net changes at fair value recognized through profit or loss 3 (282 ) - - - 12 - - (267 ) SAFE conversion - - - - - (314 ) - - (314 ) Balance as of June 30, 2023 16 117 4 400 520 - 400 250 1,707 F. The following table presents the Level 3 financial assets - loans to associates and others roll-forward during the six months ended June 30, 2023: Loan to Loan to Loan to Total Balance as of January 1, 2023 62 940 - 1,002 Loans granted to associates and others - - 80 80 Net changes at fair value recognized through profit or loss - (46 ) - (46 ) Balance as of June 30, 2023 62 894 80 1,036 G. The following table presents the level 1 and level 3 fair value financial assets included in other receivables roll-forward during the six months ended June 30, 2023: Shares receivable Total USD in thousands Balance as of January 1, 2023 - - Shares receivable from the Amendment of the Buffalo Agreement 937 937 Transfer to investments in shares (178 ) (178 ) Net changes at fair value recognized through profit or loss (153 ) (153 ) Balance as of June 30, 2023 606 606 Financial liabilities Level 1 financial liabilities: As of June 30, 2023, and December 31, 2022, the Group has a financial liability measured at level 1 - Warrants C (see note 6b). The fair value of financial instruments traded in active markets is based on quoted market prices at the statement of financial position date. A market is regarded as active if quoted prices are readily and regularly available from an exchange, dealer, broker, industry group, pricing service, or regulatory agency, and those prices represent actual and regularly occurring market transactions on an arm’s length basis. Level 3 financial liabilities: As of June 30, 2023, and December 31, 2022, the Group has financial liabilities measured at level 3 - derivative liabilities of Jeffs’ Brands (see note 3E). The fair value of the derivative liabilities of Jeffs’ Brands as of June 30, 2023, was calculated using the following unobservable inputs: share price: USD 0.75, expected volatility: 100%, exercise price: USD 2.02, risk-free interest rate: 5.4%, expected life: 4.41 years, weighted average cost of capital (WACC): 23.2%. H. The following table presents the financial liabilities that were measured at fair value through profit or loss: June 30, December 31, 2023 2022 Level 1 Level 3 Total Level 1 Level 3 Total USD in thousands USD in thousands Fair value of warrants 158 3,142 3,300 396 4,159 4,555 I. The following table presents the Level 1 financial liabilities roll-forward: Warrants USD Balance as of January 1, 2023 396 Change in fair value of warrants issued to investors (238 ) Balance as of June 30, 2023 158 J. The following table presents the Level 3 financial liabilities roll-forward: Warrants USD Balance as of January 1, 2023 4,159 Change in fair value of warrants in connection with the IPO of Jeffs’ Brands (1,017 ) Balance as of June 30, 2023 3,142 |
Goodwill and Inatangible Assets
Goodwill and Inatangible Assets | 6 Months Ended |
Jun. 30, 2023 | |
Goodwill and Inatangible Assets [Abstract] | |
GOODWILL AND INATANGIBLE ASSETS | NOTE 5 - GOODWILL AND INATANGIBLE ASSETS A. Details of the Company’s Intangible assets: June 30, December 31, 2023 2022 Unaudited Audited USD in thousands Technology 9,085 10,052 Customer relationship 5,050 5,492 Software license 1,299 1,366 Patent 75 75 Brand name 6,480 4,809 Goodwill 9,047 9,068 Intangible assets, net 31,036 30,862 B. Additions during the period: Following the Fort Acquisition, an amount of USD 2,031 thousand was recorded as additional Brand name. For additional information, see note 3E. |
Equity
Equity | 6 Months Ended |
Jun. 30, 2023 | |
Equity [Abstract] | |
EQUITY | NOTE 6 - EQUITY a. Share capital: 1) Composed as follows: Number of shares Authorized Issued and paid June 30, December 31, June 30, December 31, 2023 2022 2023 2022 In thousands Ordinary shares of no-par value 200,000 200,000 25,525 24,661 2) The ordinary shares confer upon their holders’ voting rights and the right to participate in shareholders’ meetings, the right to receive dividends and the right to participate in surplus assets in the event of liquidation of the Company. 3) On June 17, 2022, the Company’s shareholders approved to increase the authorized number of shares from 50 million to 200 million. 4) On July 7, 2022, the Company effected a reverse split of the Company’s authorized and outstanding ordinary shares at a ratio of 20:1 (the “Reverse Split”) and increased the authorized number of shares. Those changes were approved by the Company’s shareholders on June 17, 2022. On July 8, 2022, following the Reverse Split, the Company effected a change in the American Depositary Share (“ADS”) ratios for its American Depositary Receipt program such that each ADS represents one ordinary share of no-par value of the Company (the “Ordinary Share”), instead of twenty (20) pre-Reverse Split Ordinary Shares. The change in the ADS ratio is a technical change made in order to align the ratio so that one ADS equals to one Ordinary Share. 5) On November 14, 2022, the Company effected a change in the ratio of ordinary shares to each of the Company’s American Depositary Shares (“ADSs”), such that after the Reverse Split is implemented each ADS will represent 15 post-Split Ordinary Shares. The effect of such consolidation was applied retrospectively for all the number of shares, warrants, related par value and others presented in this note and elsewhere in the interim condensed consolidated financial statements. 6) On June 9, 2023, the Company issued 863,100 ordinary shares to Metagramm as part of the share purchase agreement. See note 3P. 7) On July 3, 2023, the Company issued 169,920 ordinary shares to Polyrizon as part of the share purchase agreement. See note 3G and 10.1. b. Share offering to the public and existing shareholders: The following table summarizes warrants outstanding as of June 30, 2023 Series Date of grant Number of exercise Expiration Warrants C(*) July 2018 176,045 52.5 July 18, 2023 Warrants C(**) July 2018 28,377 52.5 July 18, 2023 HCW warrants(*) July 2018 13,242 65.63 July 18, 2023 Total 217,664 * These warrants, under certain circumstances, can be exercised via cashless exercise mechanism as defined in the warrant agreement. Therefore, the warrants were classified as financial liabilities measured at fair value through profit or loss at each reporting period (see note 4). ** Recorded in equity. *** Adjusted to reflect the 1:15 ratio change of the Company’s American Depositary Receipt, or ADR, program. As a result, the number of ordinary shares of the Company represented by each American Depositary Share, or ADS, will be changed from one (1) ordinary share to fifteen (15) ordinary shares. The effective date for the ratio change was November 14, 2022 c. Share based payments In August 2013, the Company board of directors approved and adopted the Company 2013 Share Option and Incentive Plan, or the 2013 Plan, which expires in August 2023. The 2013 Plan provides for the issuance of shares and the granting of options, restricted shares, restricted share units and other share-based awards to employees, directors, officers, consultants, advisors, and service providers of us and the Company U.S. Subsidiary. The Plan provides for awards to be issued at the determination of The Company board of directors in accordance with applicable law. In June 2021, the Company board of directors approved the grant of 1,280,000 options pursuant to the Company’s option plan, to certain employees, consultants and directors. In October 2021, the Company board of directors approved the grant of 90,000 options to consultants. d. Dividends In December 2022, the Company distributed dividends in an aggregated amount of USD 1,582 thousand. e. Restricted Share Units On June 15, 2023, the Board approved a grant of restricted share units (RSUs) to the Company’s Directors, Chief Executive Officer (“CEO”), Chief Financial Officer (“CFO”), employees and to an advisor of the Company, subject to the approval of the General Meeting. On August 7, 2023, the General Meeting approved the RSUs grants. The RSUs shall vest over a period of three years commencing on January 1, 2023, with 1/12 of such options vesting at the end of each subsequent three-month period following the grant. The RSUs grant will be in accordance and pursuant to Section 102 of the Income Tax Ordinance [New Version] (“Tax Ordinance”), if applicable, and the RSUs will be accelerated upon the closing of a material transaction, resulting in change of control of the Company. During the six-month period ended June 30, 2023, the Company recognized an expense in the aggregated amount of USD 276 thousand in relation to these RSUs. |
Transactions and Balances with
Transactions and Balances with Related Parties | 6 Months Ended |
Jun. 30, 2023 | |
Transactions and Balances with Related Parties [Abstract] | |
TRANSACTIONS AND BALANCES WITH RELATED PARTIES | NOTE 7 - TRANSACTIONS AND BALANCES WITH RELATED PARTIES “Related Parties” - As defined in IAS 24 - ‘Related Party Disclosures” (hereinafter- “IAS 24”) Key management personnel of the Company - included together with other entities, in the said definition of “Related Parties” mentioned in IAS 24. a. Transactions with related parties: 1) Composed as follows: Six months ended 2023 2022 USD in thousands Payroll and related expenses to related parties employed by the Company (1) 1,032 496 Compensation to directors (2) 578 418 Directors’ and Officers’ insurance 468 453 Consultant services (3) 95 - Interest and discount amortizations of loans from Jeffs’ Brands related parties (4) - 40 Finance expense on Screenz payable balance (see note 3D) - 192 Compensation to member of senior management of Gix Internet (5) 102 - Eventer sales and marketing expenses to Keshet (see note 3D) - 165 Eventer revenues from related parties 15 7 Eventer general and administrative expenses to Screenz - 23 Jeffs’ Brands cost of revenues from related parties (6) 313 - Jeffs’ Brands income from related parties (7) 158 - (1) Includes granted options benefit in the aggregated amount of USD 56 thousand and USD 160 thousand for the six months period ended June 302023, and 2022, respectively. Also Includes grant of restricted share units (RSUs) in the aggregated amount of USD 181 thousand for the six months period ended June 30, 2023. (2) Includes granted options benefit in the aggregated amount of USD 87 thousand, USD and 183 thousand for the six months period ended June 30, 2023, and 2022, respectively. (3) Includes consulting fees to Kfir Zilberman who is a related party of the Company’s subsidiary Jeffs’ Brands (4) Includes interest and discount amortizations of loans to Julia Gerasimova, and Victor Hakmon who are related parties of the Company’s subsidiary Jeffs’ Brands. (5) Cortex CTO is a related party of Gix Internet. (6) Includes inventory storage expenses to Pure NJ Logistics LLC who is a related party of the Company’s subsidiary Jeffs’ Brands. See also note 3E. (7) Includes consulting income and a one-time signing bonus from SciSparc Nutraceuticals who is a related party of the Company’s subsidiary Jeffs’ Brands. See also note 3E. 2) Indemnification, exemption and insurance for directors and officers of the Company: a. The Company provides its directors and officers with an obligation for indemnification and exemption. b. The Company has a liability for insurance of directors and officers covering all of the Company’s directors and officers. The Company currently has directors’ and officers’ liability insurance providing total coverage of USD 4 million for the benefit of all of the Company directors and officers, in respect of which the Company are charged a twelve-month premium of USD 195, and which includes a deductible of up to USD 1 million per claim, other than securities related claims filed in the United States or Canada, for which the deductible will not exceed USD 2.5 million and USD 5 million in respect of claim with respect to Mergers and Acquisitions. 3) Transactions during the six months period ended June 30, 2023: a. On January 23, 2023, Gix Media acquired an additional 10% of the share capital of Cortex. See note 3F. b. In February 2023, the Company and other lenders, signed a convertible loan agreement with Polyrizon. See note 3G. c. On March 22, 2023, Jeffs’ Brands entered into a consulting agreement with SciSparc Nutraceuticals. See note 3E. d. In March 2023, Jeff’s Brands paid to Pure Capital USD 352 thousand in accordance with the consultant agreement in relation to the two purchases of Fort and SciSparc Nutraceuticals. The consultancy fees were recorded as part of the investments in Fort and SciSparc Nutraceuticals. e. On March 28, 2023, the Company signed a security exchange agreement with Fuel Doctor to sell all its shares in Charging Robotics to Fuel Doctor. See note 3J. f. On April 13, 2023, the Company entered into a loan agreement with Metagramm. See note 3P. g. In June 2023, the Company and other investors signed a share purchase agreement with Polyrizon. See note 3G. h. In June 2023, the Company signed an amendment to the credit facility agreement with Parazero. See note 3K. b. Balances with related parties: (1) Current assets under related parties section: June 30, December 31, 2023 2022 USD in thousands Advances to Pure Logistics (a related party of Jeffs’ Brands) 7 228 Receivables from SciSparc Nutraceuticals (a related party of Jeffs’ Brands) 168 - Other receivables (a related party of Gix Internet) 58 60 Other receivables (a related party of Eventer) 5 10 238 298 (2) Current assets under loans to associates section: June 30, December 31, 2023 2022 USD in thousands Loan to Laminera (note 3L) 88 93 Loan to Revoltz (note 3H) 141 62 Loan to Metagramm (note 3P) 167 - Credit line to Parazero (note 3K) 785 391 1,181 546 (3) Current Liabilities: June 30, December 31, 2023 2022 USD in thousands Compensation to key management personnel (*) 685 649 Other payable dividend to related parties of Gix Internet - 284 Current liabilities to related parties of Jeffs’ Brands 118 - Other accrued expenses to related parties of Eventer 8 122 811 1,055 * As of June 30, 2023, these balances include compensation to key management personnel of the Company, Eventer, Gix Internet, Fuel Doctor and Jeffs’ Brands. |
Revenues
Revenues | 6 Months Ended |
Jun. 30, 2023 | |
Revenue [Abstract] | |
REVENUES | NOTE 8 - REVENUES a. Disaggregation of Revenues: The following table present the Group’s revenues disaggregated by revenue type: Six months ended 2023 2022 USD in thousands Revenues from commissions (from Eventer) 1,498 1,472 Products (from Jeffs’ Brands) 3,871 2,343 Revenues from internet services (from Gix Internet) 48,016 (*) 31,144 53,385 34,959 * The revenues from Gix Internet are presented for the period from March 1, 2022, to June 30, 2022. b. Major customers Set forth below is a breakdown of Company’s revenue by major customers (major customer -revenues from these customers constitute at least 10% of total revenues in a certain year): YTD ended on 2023 2022 USD in thousands Customer A 7,753 6,458 Customer B 8,109 5,124 |
Segments
Segments | 6 Months Ended |
Jun. 30, 2023 | |
Segments [Abstract] | |
SEGMENTS | NOTE 9 - SEGMENTS The Group identified eight operating segments as follows: medical, e-commerce, online advertising and internet traffic routing, online event management, safety systems for commercial drones, energy efficiency technology, electric vehicles and corporate (see note 1a). The Company concluded that the medical, electric vehicles, safety systems for commercial drones and energy efficiency technology segments are not “reportable segments” as defined in IFRS 8, Operating Segments The CODM measures and evaluates the operating performance of the Group’s segments based on operating loss (income), assets and liabilities. The table set forth other information of the Group: June 30, 2023 Corporate E-commerce Online Online Others Adjustments Total USD in thousands Total segments’ assets 16,660 16,096 45,680 3,936 *3,588 (293 ) 85,667 Total segments’ liabilities (1,204 ) (5,500 ) (31,868 ) (2,821 ) (177 ) 350 (41,220 ) * Includes investments accounted for using the equity method of USD 592 thousand in relation to Parazero (note 3K), USD 1,142 thousand in relation to Laminera (note 3L) and USD 643 thousand in relation to Polyrizon (note 3G). December 31, 2022 Corporate E-commerce Online Online Others Adjustments Total USD in thousands Total segments’ assets 19,478 15,667 50,999 3,208 11,368 (3,069 ) 97,651 Total segments’ liabilities (1,198 ) (5,025 ) (33,203 ) (3,244 ) (952 ) 660 (42,962 ) The table set forth the operating results of the Group: Period ended June 30, 2023 Corporate E-commerce Online Online Others Adjustments Total USD in thousands External revenues - 3,871 48,016 1,498 - - 53,385 Segment results - operating income (loss) (6,301 ) (2,131 ) (46 ) 140 (1,452 )* - (9,790 ) Non-operating income 157 1,252 - - - - 1,409 Finance income (loss) (219 ) (193 ) (765 ) (55 ) (7 ) 261 (978 ) Profit (Loss) before taxes on income (6,363 ) (1,072 ) (811 ) 85 (1,459 ) 261 (9,359 ) Tax benefit (expense) on income 3 (9 ) (340 ) - - 169 (177 ) Segment results - profit (loss) (6,360 ) (1,081 ) (1,151 ) 85 (1,459 ) 430 (9,536 ) * Includes equity losses of USD 655 thousand in relation to Odysight.ai (note 3C), USD 384 thousand in relation to Parazero (note 3K), USD 34 thousand in relation to Laminera (note 3L) and USD 65 thousand in relation to Polyrizon (note 3G). Six months ended June 30, 2022 Corporate E-commerce Online Online Others Adjustments Total USD in thousands External revenues - 2,343 31,144 1,472 - - 34,959 Segment results - operating income (loss) (3,366 ) (1,098 ) 638 * (310 ) (1,385 )** (807 ) (6,328 ) Non-operating income (loss) 64 (63 ) (56 ) - 137 2,300 2,382 Finance income (loss) 330 (272 ) (620 ) (277 ) (2 ) 48 (793 ) Profit (Loss) before taxes on income (2,972 ) (1,433 ) (38 ) (587 ) (1,250 ) 1,541 (4,739 ) Tax benefit (expense) on income (5 ) (93 ) (15 ) - (6 ) 110 (9 ) Segment results - profit (loss) (2,977 ) (1,526 ) (53 ) (587 ) (1,256 ) 1,651 (4,748 ) * Includes equity loss of USD 215 thousands in relation to Gix Internet. ** Includes equity loss of USD 1,073 thousands in relation to Odysight.ai. |
Subsequent Events
Subsequent Events | 6 Months Ended |
Jun. 30, 2023 | |
Subsequent Events [Abstract] | |
SUBSEQUENT EVENTS | NOTE 10 - SUBSEQUENT EVENTS 1. On July 3, 2023, the Company issued 169,920 shares to Polyrizon following the share purchase agreement signed in June 2023. See note 3G. 2. On July 11, 2023, the Company received the consideration for the sale of Odysight.ai in the amount of USD 5.7 million. See note 3C. 3. On July 19, 2023, warrants C were removed from the trading list due to expiration. 4. On July 20, 2023, Viewbix granted 51,020 RSUs to Viewbix’s Chief Executive Officer (“CEO”). 5. On July 31, 2023, Parazero completed its initial public offering (“IPO”) on the Nasdaq for aggregated gross proceeds of approximately USD 7.8 million before deducting underwriting discounts and other estimated offering expenses. The Company participated in the IPO in an amount of USD 1.5 million and converted all of the SAFEs into ordinary shares. Following the IPO and the SAFEs conversion, the Company’s holdings in Parazero decreased to 33.36%. In addition, following the IPO, the credit facility was fully repaid to the Company in the amount of USD 785 thousand. 6. On August 1, 2023, the Company received additional 21,000 shares of SciSparc in connection with the Amendment to the Buffalo Agreement signed on March 16, 2023. See note 3I. 7. On August 7, 2023, the Company’s General Meeting approved the re-election of Mr. Eli Cohen to serve as a Director of the Company, a grant of RSUs to the Company’s Chief Executive Officer (“CEO”), Chief Financial Officer (“CFO”), the Company’s Directors, employees and to an advisor as well as the re-appointment of Brightman Almagor Zohar & Co., a member firm of Deloitte Touche Tohmatsu Limited, as the Company’s independent auditors for the year ending December 31, 2023. 8. On August 30, 2023, the Company and Gix Internet signed an addendum to the Loan Agreement, effective as of June 30, 2023. Pursuant to the addendum, the loan repayment will be postponed until January 1, 2024. See note 3F. 9. On September 5, 2023, the General Meeting of A.I. Systems approved the loan conversion. As a result, the loan was converted into 2,650,423 shares of A.I. Systems which represents 36% holdings of the issued and outstanding shares of A.I. Systems. See note 3Q. 10. On September 13, 2023, the Company signed an operating agreement with a company based in Miami, Florida, to invested USD 2,000 thousand in a joint venture between the parties. The Company will hold 60% of the joint venture and the US based partner will hold the remaining 40%. Once the initial contribution by the company will be fully repaid, the Company will hold a 30% in the property. The joint venture purpose is to acquire, improve, renovate, develop, sell and otherwise deal with a commercial property located in Miami. |
Interest in Other Entities (Tab
Interest in Other Entities (Tables) | 6 Months Ended |
Jun. 30, 2023 | |
Interest in Other Entities [Abstract] | |
Schedule of General Information | General information Main place of Ownership rights held by the Company % Ownership rights held by non- controlling interests % June 30, 2023 Jeffs’ Brands Israel 34.87 65.13 Eventer Israel 46.21 53.79 Fuel Doctor USA 67 33 GERD IP USA 90 10 Gix Internet Israel 42.25 57.75 Main place of Ownership rights held by the Company % Ownership rights held by non- controlling interests % December 31, 2022 Jeffs’ Brands Israel 35.94 64.06 Eventer Israel 46.21 53.79 Charging Robotics Israel 100 - GERD IP USA 90 10 Gix Internet Israel 42.25 57.75 |
Schedule of Statement of Financial Position | Summarized statement of financial position: June 30, December 31, USD in thousands (*) Current assets 2,044 1,829 Non-current assets 1,315 1,379 Current liabilities 3,234 2,766 Non-current liabilities - 476 Equity (Deficit) 125 (34 ) (*) Translated according to the exchange rate at the date of each statement of financial position. June 30, December 31, USD in thousands Current assets 5,457 11,033 Non-current assets 9,622 4,743 Current liabilities 5,239 5,133 Non-current liabilities 88 98 Equity 9,752 10,545 June 30, December 31, USD in thousands (*) Current assets 22,701 26,481 Non-current assets 15,367 16,549 Current liabilities 27,692 29,529 Non-current liabilities 4,069 4,127 Equity 6,307 9,374 Equity attributable to Gix Internet shareholders 2,517 4,804 Non-controlling interests 3,790 4,570 |
Schedule of Comprehensive Income | Summarized statement of comprehensive income: Six months ended June 30, 2023 2022 USD in thousands (**) Revenues 1,498 1,472 Net profit (loss) for the period 111 (587 ) Summarized statement of comprehensive income: Six months ended June 30, 2023 2022 USD in thousands Revenues 3,871 2,343 Net loss for the period (1,079 ) (1,526 ) Six months March 1, USD in thousands (**) Revenues 48,016 31,144 Net profit (loss) for the period (122 ) 164 |
Schedule of Cash Flows | Summarized statement of cash flows: Six months ended June 30, 2023 2022 USD in thousands (**) Cash flow from operating activities 199 1,235 Cash flow used in investing activities (6 ) (6 ) Cash flow used in financing activities - (146 ) Losses from exchange differences on cash and cash equivalents (79 ) (288 ) Net increase in cash and cash equivalents 114 795 (**) Translated according to the average exchange rates for each period. Six months ended June 30, 2023 2022 USD in thousands Cash flow used in operating activities (749 ) (1,054 ) Cash flow used in investing activities (4,998 ) (3 ) Cash flow from (used in) financing activities (119 ) 731 Net decrease in cash and cash equivalents (5,866 ) (326 ) Six months March 1, USD in thousands (**) Cash flow from operating activities 993 989 Cash flow used in investing activities (8 ) (9 ) Cash flow from (used in) financing activities (1,851 ) 1,661 Gain from exchange differences on cash and cash equivalents 109 51 Net increase (decrease) in cash and cash equivalents (757 ) 2,692 (**) translated at average exchange rates for each period. |
Schedule of Non-Controlling Interest | Balance of non-controlling interests: June 30, December 31, USD in thousands Eventer 860 721 Jeffs’ Brands 6,727 7,199 Charging Robotics - 91 Gix Internet 4,724 7,480 GERD IP 57 57 Fuel Doctor 316 - 12,684 15,548 |
Schedule of Profit (Loss) Attributed to Non-Controlling Interest | Profit (Loss) attributed to non-controlling interests: Six months ended June 30, 2023 2022 USD in thousands Eventer 88 (307 ) Jeffs’ Brands (661 ) (793 ) Gix Internet (668 ) (65 ) GERD IP - 7 Fuel Doctor (95 ) - (1,336 ) (1,158 ) |
Schedule of Total Investment According to the Equity Method | This table summarizes the total investments accounted for using the equity method: June 30, December 31, USD in thousands Odysight.ai (note 3C) - 9,375 Parazero (note 3K) 592 976 Laminera (note 3L) 1,142 1,176 Polyrizon (note 3G) 643 214 SciSparc Nutraceuticals (note 3E) 2,944 - Revoltz (note 3H) 133 151 5,454 11,892 |
Schedule of Summarizes the Total Loss From Investments Accounted for Using the Equity Method | This table summarizes the total equity losses from investments accounted for using the equity method: Six months ended June 30, 2023 2022 USD in thousands Odysight.ai (note 3C) 655 1,073 Gix Internet (note 3F) - 215 Parazero (note 3K) 384 295 Laminera (note 3L) 34 81 Polyrizon (note 3G) 65 159 Elbit Imaging - 78 SciSparc Nutraceuticals (note 3E) 89 - Revoltz (note 3H) 11 9 1,238 1,910 |
Schedule of Summarize the Company’s Rights in Share Capital and Voting Rights | This table summarize the Company’s rights in share capital and voting rights: Main place of business Company rights in share June 30, 2023 Parazero Israel 40.35 % Laminera Israel 19.70 % Polyrizon Israel 40.22 % Revoltz Israel 19.90 % SciSparc Nutraceuticals USA 49.9 % December 31, 2022 Parazero Israel 40.35 % Laminera Israel 19.70 % Polyrizon Israel 37.03 % Revoltz Israel 19.90 % Odysight.ai Israel 27.02 % Fuel Doctor Israel 28.63 % |
Schedule of Activity in Investment Account | Activity in investment account: January 1, 2023- USD Investment as of January 1, 2023 9,375 Loss for the period (655 ) Balance as of March 21, 2023 8,720 Loss as a result of transition to FVTPL (2,946 ) Fair value of the investment as of March 21, 2023 5,774 February 23, 2023 – USD Balance as of January 1, 2023 - Purchase on February 23, 2023 3,033 Loss for the period (89 ) Balance as of June 30, 2023 2,944 For the USD Balance as of January 1, 2023 214 Loss for the period (65 ) Additional purchase on June 20, 2023 180 Safe conversion into shares 314 Balance as of June 30, 2023 643 For the USD Balance as of January 1, 2023 976 Loss for the period (384 ) Balance as of June 30, 2023 592 For the USD Balance as of January 1, 2023 1,176 Loss for the period (20 ) Excess cost amortization (14 ) Balance as of June 30, 2023 1,142 |
Schedule of Short Term Loans | Short term loans: June 30, December 31, USD in thousands Short term bank loans 5,973 5,025 Current maturities of long-term loans 1,879 1,500 7,852 6,525 |
Schedule of Long Term Loans | Long term loans: June 30, December 31, USD in thousands Long term bank loans 3,128 2,881 3,128 2,881 |
Financial Instruments (Tables)
Financial Instruments (Tables) | 6 Months Ended |
Jun. 30, 2023 | |
Financial Instruments and Financial Risk Management [Abstract] | |
Schedule of Fair Value Financial Assets | The following table presents the level 1 and level 3 fair value financial assets - investments in shares, warrants and SAFEs as of June 30, 2023, and December 31, 2022 June 30, 2023 December 31, 2022 Level 1 Level 3 Total Level 1 Level 3 Total USD in thousands Safo shares 8 - 8 10 - 10 Maris shares 110 - 110 84 - 84 Maris warrants - 16 16 - 13 13 Tondo shares 101 - 101 97 - 97 Safee shares (note 3N) - 400 400 - 400 400 SciSparc shares (notes 3I and 3E) 233 - 233 659 - 659 Polyrizon warrants (note 3G) - 117 117 - 399 399 Polyrizon SAFEs (note 3G) - - - - 302 302 Elbit Imaging shares 578 - 578 613 - 613 Hydreight Technologies shares (note 3I) 109 - 109 - - - Clearmind warrants (note 3M) - 4 4 - 4 4 A.I Systems shares (note 3Q) 47 - 47 - - - Clearmind shares (note 3M) 90 - 90 594 - 594 Metagramm shares (note 3P) - 250 250 - - - Colugo shares - 400 400 - 400 400 Parazero SAFEs (note 3K) - 520 520 - 520 520 Bubbles shares 106 - 106 151 - 151 Automax warrants 6 - 6 9 - 9 Automax shares 341 - 341 1,114 - 1,114 Total 1,729 1,707 3,436 3,331 2,038 5,369 The following table presents the level 1 and level 3 fair value financial assets – loans to associates and others as of June 30, 2023, and December 31, 2022 June 30, 2023 December 31, 2022 Level 1 Level 3 Total Level 1 Level 3 Total USD in thousands Loan to Revoltz (note 3H) - 62 62 - 62 62 Loan to Polyrizon (note 3G) - 80 80 - - - Loan to A.I Systems (note 3Q) - 894 894 - 940 940 Total - 1,036 1,036 - 1,002 1,002 The following table presents the level 1 and level 3 fair value financial assets included in other receivables as of June 30, 2023, and December 31, 2022 June 30, 2023 December 31, 2022 Level 1 Level 3 Total Level 1 Level 3 Total USD in thousands Shares receivable (note 3I) 106 500 606 - - - Total 106 500 606 - - - |
Schedule of Fair Value of Financial Instruments | The following table presents the Level 1 financial assets - investments in shares and warrants roll-forward during the six months ended June 30, 2023: Safo Tondo A.I Bubbles Hydreight SciSparc Maris Automax Odysight.ai Clearmind Elbit Automax Total USD in thousands Balance as of January 1, 2023 10 97 - 151 - 659 84 9 - 594 613 1,114 3,331 Purchase of securities - - 83 - 141 325 - - - - - - 549 Transfer from equity method - - - - - - - - 8,720 - - - 8,720 Net changes at fair value recognized through profit or loss (2 ) 4 (36 ) (45 ) (32 ) 320 26 (3 ) (2,946 ) (504 ) 185 (773 ) (3,806 ) Sale of securities - - - - - (1,045 ) - - (5,774 ) - (220 ) - (7,039 ) Realized loss - - - - - (26 ) - - - - - - (26 ) Balance as of June 30, 2023 8 101 47 106 109 233 110 6 - 90 578 341 1,729 (*) For more information, see note 3C. Maris Polyrizon Clearmind Safee Parazero s Polyrizon Colugo Metagramm Total USD in thousands Balance as of January 1, 2023 13 399 4 400 520 302 400 - 2,038 Purchase of securities - - - - - - - 250 250 Net changes at fair value recognized through profit or loss 3 (282 ) - - - 12 - - (267 ) SAFE conversion - - - - - (314 ) - - (314 ) Balance as of June 30, 2023 16 117 4 400 520 - 400 250 1,707 The following table presents the Level 3 financial assets - loans to associates and others roll-forward during the six months ended June 30, 2023: Loan to Loan to Loan to Total Balance as of January 1, 2023 62 940 - 1,002 Loans granted to associates and others - - 80 80 Net changes at fair value recognized through profit or loss - (46 ) - (46 ) Balance as of June 30, 2023 62 894 80 1,036 The following table presents the level 1 and level 3 fair value financial assets included in other receivables roll-forward during the six months ended June 30, 2023: Shares receivable Total USD in thousands Balance as of January 1, 2023 - - Shares receivable from the Amendment of the Buffalo Agreement 937 937 Transfer to investments in shares (178 ) (178 ) Net changes at fair value recognized through profit or loss (153 ) (153 ) Balance as of June 30, 2023 606 606 |
Schedule of Financial Liabilities that were Measured at Fair Value | The following table presents the financial liabilities that were measured at fair value through profit or loss: June 30, December 31, 2023 2022 Level 1 Level 3 Total Level 1 Level 3 Total USD in thousands USD in thousands Fair value of warrants 158 3,142 3,300 396 4,159 4,555 |
Schedule of Level 1 Financial Liabilities | The following table presents the Level 1 financial liabilities roll-forward: Warrants USD Balance as of January 1, 2023 396 Change in fair value of warrants issued to investors (238 ) Balance as of June 30, 2023 158 The following table presents the Level 3 financial liabilities roll-forward: Warrants USD Balance as of January 1, 2023 4,159 Change in fair value of warrants in connection with the IPO of Jeffs’ Brands (1,017 ) Balance as of June 30, 2023 3,142 |
Goodwill and Inatangible Asse_2
Goodwill and Inatangible Assets (Tables) | 6 Months Ended |
Jun. 30, 2023 | |
Goodwill and Inatangible Assets [Abstract] | |
Schedule of Company’s Intangible Assets | Details of the Company’s Intangible assets: June 30, December 31, 2023 2022 Unaudited Audited USD in thousands Technology 9,085 10,052 Customer relationship 5,050 5,492 Software license 1,299 1,366 Patent 75 75 Brand name 6,480 4,809 Goodwill 9,047 9,068 Intangible assets, net 31,036 30,862 |
Equity (Tables)
Equity (Tables) | 6 Months Ended |
Jun. 30, 2023 | |
Equity [Abstract] | |
Schedule of Share Capital | Composed as follows: Number of shares Authorized Issued and paid June 30, December 31, June 30, December 31, 2023 2022 2023 2022 In thousands Ordinary shares of no-par value 200,000 200,000 25,525 24,661 |
Schedule of Warrants Outstanding | The following table summarizes warrants outstanding as of June 30, 2023 Series Date of grant Number of exercise Expiration Warrants C(*) July 2018 176,045 52.5 July 18, 2023 Warrants C(**) July 2018 28,377 52.5 July 18, 2023 HCW warrants(*) July 2018 13,242 65.63 July 18, 2023 Total 217,664 * These warrants, under certain circumstances, can be exercised via cashless exercise mechanism as defined in the warrant agreement. Therefore, the warrants were classified as financial liabilities measured at fair value through profit or loss at each reporting period (see note 4). ** Recorded in equity. *** Adjusted to reflect the 1:15 ratio change of the Company’s American Depositary Receipt, or ADR, program. As a result, the number of ordinary shares of the Company represented by each American Depositary Share, or ADS, will be changed from one (1) ordinary share to fifteen (15) ordinary shares. The effective date for the ratio change was November 14, 2022 |
Transactions and Balances wit_2
Transactions and Balances with Related Parties (Tables) | 6 Months Ended |
Jun. 30, 2023 | |
Transactions and Balances with Related Parties [Abstract] | |
Schedule of Transactions with Related Parties | Composed as follows: Six months ended 2023 2022 USD in thousands Payroll and related expenses to related parties employed by the Company (1) 1,032 496 Compensation to directors (2) 578 418 Directors’ and Officers’ insurance 468 453 Consultant services (3) 95 - Interest and discount amortizations of loans from Jeffs’ Brands related parties (4) - 40 Finance expense on Screenz payable balance (see note 3D) - 192 Compensation to member of senior management of Gix Internet (5) 102 - Eventer sales and marketing expenses to Keshet (see note 3D) - 165 Eventer revenues from related parties 15 7 Eventer general and administrative expenses to Screenz - 23 Jeffs’ Brands cost of revenues from related parties (6) 313 - Jeffs’ Brands income from related parties (7) 158 - (1) Includes granted options benefit in the aggregated amount of USD 56 thousand and USD 160 thousand for the six months period ended June 302023, and 2022, respectively. Also Includes grant of restricted share units (RSUs) in the aggregated amount of USD 181 thousand for the six months period ended June 30, 2023. (2) Includes granted options benefit in the aggregated amount of USD 87 thousand, USD and 183 thousand for the six months period ended June 30, 2023, and 2022, respectively. (3) Includes consulting fees to Kfir Zilberman who is a related party of the Company’s subsidiary Jeffs’ Brands (4) Includes interest and discount amortizations of loans to Julia Gerasimova, and Victor Hakmon who are related parties of the Company’s subsidiary Jeffs’ Brands. (5) Cortex CTO is a related party of Gix Internet. (6) Includes inventory storage expenses to Pure NJ Logistics LLC who is a related party of the Company’s subsidiary Jeffs’ Brands. See also note 3E. (7) Includes consulting income and a one-time signing bonus from SciSparc Nutraceuticals who is a related party of the Company’s subsidiary Jeffs’ Brands. See also note 3E. * As of June 30, 2023, these balances include compensation to key management personnel of the Company, Eventer, Gix Internet, Fuel Doctor and Jeffs’ Brands. |
Schedule of Current Assets Under Related Parties | Current assets under related parties section: June 30, December 31, 2023 2022 USD in thousands Advances to Pure Logistics (a related party of Jeffs’ Brands) 7 228 Receivables from SciSparc Nutraceuticals (a related party of Jeffs’ Brands) 168 - Other receivables (a related party of Gix Internet) 58 60 Other receivables (a related party of Eventer) 5 10 238 298 |
Schedule of Current Assets Under Loans to Associates | Current assets under loans to associates section: June 30, December 31, 2023 2022 USD in thousands Loan to Laminera (note 3L) 88 93 Loan to Revoltz (note 3H) 141 62 Loan to Metagramm (note 3P) 167 - Credit line to Parazero (note 3K) 785 391 1,181 546 |
Schedule of Current Liabilities | Current Liabilities: June 30, December 31, 2023 2022 USD in thousands Compensation to key management personnel (*) 685 649 Other payable dividend to related parties of Gix Internet - 284 Current liabilities to related parties of Jeffs’ Brands 118 - Other accrued expenses to related parties of Eventer 8 122 811 1,055 * As of June 30, 2023, these balances include compensation to key management personnel of the Company, Eventer, Gix Internet, Fuel Doctor and Jeffs’ Brands. |
Revenues (Tables)
Revenues (Tables) | 6 Months Ended |
Jun. 30, 2023 | |
Revenue [Abstract] | |
Schedule of Group’s Revenues Disaggregated by Revenue | The following table present the Group’s revenues disaggregated by revenue type: Six months ended 2023 2022 USD in thousands Revenues from commissions (from Eventer) 1,498 1,472 Products (from Jeffs’ Brands) 3,871 2,343 Revenues from internet services (from Gix Internet) 48,016 (*) 31,144 53,385 34,959 * The revenues from Gix Internet are presented for the period from March 1, 2022, to June 30, 2022. |
Schedule of Breakdown of Company’s Revenue by Major Customers | Set forth below is a breakdown of Company’s revenue by major customers YTD ended on 2023 2022 USD in thousands Customer A 7,753 6,458 Customer B 8,109 5,124 |
Segments (Tables)
Segments (Tables) | 6 Months Ended |
Jun. 30, 2023 | |
Segments [Abstract] | |
Schedule of Group’s Segments Based on Operating Loss (Income), Assets and Liabilities | The table set forth other information of the Group: June 30, 2023 Corporate E-commerce Online Online Others Adjustments Total USD in thousands Total segments’ assets 16,660 16,096 45,680 3,936 *3,588 (293 ) 85,667 Total segments’ liabilities (1,204 ) (5,500 ) (31,868 ) (2,821 ) (177 ) 350 (41,220 ) * Includes investments accounted for using the equity method of USD 592 thousand in relation to Parazero (note 3K), USD 1,142 thousand in relation to Laminera (note 3L) and USD 643 thousand in relation to Polyrizon (note 3G). December 31, 2022 Corporate E-commerce Online Online Others Adjustments Total USD in thousands Total segments’ assets 19,478 15,667 50,999 3,208 11,368 (3,069 ) 97,651 Total segments’ liabilities (1,198 ) (5,025 ) (33,203 ) (3,244 ) (952 ) 660 (42,962 ) Period ended June 30, 2023 Corporate E-commerce Online Online Others Adjustments Total USD in thousands External revenues - 3,871 48,016 1,498 - - 53,385 Segment results - operating income (loss) (6,301 ) (2,131 ) (46 ) 140 (1,452 )* - (9,790 ) Non-operating income 157 1,252 - - - - 1,409 Finance income (loss) (219 ) (193 ) (765 ) (55 ) (7 ) 261 (978 ) Profit (Loss) before taxes on income (6,363 ) (1,072 ) (811 ) 85 (1,459 ) 261 (9,359 ) Tax benefit (expense) on income 3 (9 ) (340 ) - - 169 (177 ) Segment results - profit (loss) (6,360 ) (1,081 ) (1,151 ) 85 (1,459 ) 430 (9,536 ) * Includes equity losses of USD 655 thousand in relation to Odysight.ai (note 3C), USD 384 thousand in relation to Parazero (note 3K), USD 34 thousand in relation to Laminera (note 3L) and USD 65 thousand in relation to Polyrizon (note 3G). Six months ended June 30, 2022 Corporate E-commerce Online Online Others Adjustments Total USD in thousands External revenues - 2,343 31,144 1,472 - - 34,959 Segment results - operating income (loss) (3,366 ) (1,098 ) 638 * (310 ) (1,385 )** (807 ) (6,328 ) Non-operating income (loss) 64 (63 ) (56 ) - 137 2,300 2,382 Finance income (loss) 330 (272 ) (620 ) (277 ) (2 ) 48 (793 ) Profit (Loss) before taxes on income (2,972 ) (1,433 ) (38 ) (587 ) (1,250 ) 1,541 (4,739 ) Tax benefit (expense) on income (5 ) (93 ) (15 ) - (6 ) 110 (9 ) Segment results - profit (loss) (2,977 ) (1,526 ) (53 ) (587 ) (1,256 ) 1,651 (4,748 ) * Includes equity loss of USD 215 thousands in relation to Gix Internet. ** Includes equity loss of USD 1,073 thousands in relation to Odysight.ai. |
General (Details)
General (Details) - USD ($) $ in Millions | 1 Months Ended | 6 Months Ended | 12 Months Ended | ||||
Mar. 28, 2023 | Aug. 28, 2022 | Aug. 30, 2022 | Feb. 28, 2022 | Jun. 30, 2023 | Dec. 31, 2022 | Mar. 21, 2023 | |
General (Details) [Line Items] | |||||||
Issued share capital rate | 76.25% | 67% | 27.02% | ||||
Capital raising transaction percentage | 18.45% | ||||||
Stock capital, percentage | 90% | ||||||
Issued and outstanding share capital percentage | 35.94% | 46.21% | |||||
Outstanding share capital rate | 67% | ||||||
Gix Internet Ltd. [Member] | |||||||
General (Details) [Line Items] | |||||||
Holdings interests percentage | 38.03% | ||||||
Gix Internet Ltd. [Member] | Bottom of range [member] | |||||||
General (Details) [Line Items] | |||||||
Issued and outstanding share capital percentage | 42.25% | ||||||
Jeffs’ Brands Ltd.[Member] | |||||||
General (Details) [Line Items] | |||||||
Issued and outstanding share capital percentage | 34.87% | ||||||
Parazero Technologies Ltd [Member] | |||||||
General (Details) [Line Items] | |||||||
Ownership interest, percentage | 40.35% | ||||||
Parazero Technologies Ltd [Member] | |||||||
General (Details) [Line Items] | |||||||
Ownership interest, percentage | 40.22% | ||||||
Laminera Flow Optimization Ltd [Member] | |||||||
General (Details) [Line Items] | |||||||
Ownership interest, percentage | 19.70% | ||||||
Polyrizon Ltd. [Member] | |||||||
General (Details) [Line Items] | |||||||
Ownership interest, percentage | 4.76% | ||||||
Elbit Imaging Ltd [Member] | |||||||
General (Details) [Line Items] | |||||||
Ownership interest, percentage | 3.79% | ||||||
Automax Ltd [Member] | |||||||
General (Details) [Line Items] | |||||||
Ownership interest, percentage | 2.64% | ||||||
SciSparc ltd [Member] | |||||||
General (Details) [Line Items] | |||||||
Ownership interest, percentage | 0.86% | ||||||
Safee Cyber Technologies Ltd. [Member] | |||||||
General (Details) [Line Items] | |||||||
Ownership interest, percentage | 2.35% | ||||||
Maris-Tech Ltd [Member] | |||||||
General (Details) [Line Items] | |||||||
Ownership interest, percentage | 1.41% | ||||||
Colugo Systems Ltd [Member] | |||||||
General (Details) [Line Items] | |||||||
Ownership interest, percentage | 0.97% | ||||||
Safe Foods, Inc. [Member] | |||||||
General (Details) [Line Items] | |||||||
Ownership interest, percentage | 0.47% | ||||||
Tondo Smart Ltd [Member] | |||||||
General (Details) [Line Items] | |||||||
Ownership interest, percentage | 0.67% | ||||||
Bubbles Intergroup Ltd [Member] | |||||||
General (Details) [Line Items] | |||||||
Ownership interest, percentage | 1.49% | ||||||
A.I Ssystems Ltd [Member] | |||||||
General (Details) [Line Items] | |||||||
Ownership interest, percentage | 4.99% | ||||||
Metagramm Software Ltd [Member] | |||||||
General (Details) [Line Items] | |||||||
Ownership interest, percentage | 19.99% | ||||||
Financial Statements [Member] | |||||||
General (Details) [Line Items] | |||||||
cash and cash equivalents (in Dollars) | $ 6.2 |
Interest in Other Entities (Det
Interest in Other Entities (Details) ₪ / shares in Units, $ / shares in Units, € in Thousands, $ in Thousands | 1 Months Ended | 4 Months Ended | 6 Months Ended | 12 Months Ended | 24 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sep. 05, 2023 shares | Jul. 03, 2023 shares | Jun. 20, 2023 USD ($) | Apr. 27, 2023 USD ($) | Apr. 13, 2023 USD ($) | Apr. 06, 2023 USD ($) shares | Mar. 21, 2023 USD ($) $ / shares shares | Mar. 02, 2023 shares | Nov. 22, 2022 ILS (₪) | Sep. 14, 2022 USD ($) | Aug. 10, 2022 USD ($) | Aug. 01, 2022 | May 09, 2022 USD ($) | Mar. 22, 2022 USD ($) | Feb. 28, 2022 USD ($) | Dec. 15, 2021 USD ($) | Dec. 07, 2021 USD ($) $ / shares shares | Oct. 13, 2021 USD ($) | Oct. 13, 2021 USD ($) | Oct. 13, 2021 ILS (₪) | Mar. 30, 2021 USD ($) ₪ / shares shares | Feb. 04, 2021 USD ($) | Feb. 04, 2021 ILS (₪) | Oct. 14, 2020 | Jul. 31, 2023 USD ($) shares | Jun. 29, 2023 USD ($) | Jun. 20, 2023 USD ($) | May 23, 2023 shares | May 17, 2023 USD ($) | Mar. 31, 2023 USD ($) | Mar. 28, 2023 shares | Mar. 23, 2023 USD ($) | Mar. 22, 2023 USD ($) shares | Mar. 16, 2023 USD ($) shares | Feb. 28, 2023 USD ($) | Jan. 23, 2023 | Nov. 28, 2022 shares | Oct. 30, 2022 USD ($) | Oct. 26, 2022 USD ($) | Oct. 26, 2022 ILS (₪) | Sep. 21, 2022 USD ($) | Aug. 30, 2022 USD ($) $ / shares shares | Aug. 23, 2022 USD ($) | Aug. 23, 2022 ILS (₪) | Jul. 28, 2022 USD ($) | Mar. 31, 2022 USD ($) shares | Jan. 28, 2022 USD ($) | Jan. 28, 2022 AUD ($) | May 31, 2022 USD ($) | Jun. 30, 2023 USD ($) $ / shares shares | Jun. 30, 2023 ILS (₪) shares | Jun. 30, 2022 USD ($) shares | Jun. 30, 2022 ILS (₪) shares | Dec. 31, 2022 USD ($) $ / shares shares | Dec. 31, 2022 ILS (₪) shares | Dec. 31, 2022 AUD ($) shares | Dec. 31, 2021 USD ($) shares | Mar. 09, 2023 USD ($) | Mar. 09, 2023 EUR (€) | Jun. 30, 2023 ILS (₪) shares | Jun. 09, 2023 shares | Apr. 23, 2023 USD ($) | Jan. 17, 2023 USD ($) | Dec. 25, 2022 USD ($) | Nov. 14, 2022 USD ($) $ / shares shares | Oct. 26, 2022 ILS (₪) | Sep. 07, 2022 USD ($) | Jun. 21, 2022 shares | May 08, 2022 USD ($) | Mar. 30, 2022 shares | Feb. 14, 2022 | Jan. 27, 2022 USD ($) | Mar. 30, 2021 ILS (₪) ₪ / shares | Mar. 09, 2021 | Jul. 31, 2020 USD ($) | Jul. 20, 2020 USD ($) shares | ||
Interest in Other Entities (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Common stock exercise price per share (in Dollars per share) | $ / shares | $ 5.5 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Company recognized loss | $ 2,946,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Total proceeds | $ 5,700,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Development services amount | $ 1,500,000 | ₪ 4,280,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Revenues earned percentage | 8% | 8% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fair value | $ 660,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt amount | 1,062,000 | ₪ 3,862,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Advertising right | 402,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Options to purchase (in Shares) | shares | 29,944 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Invested an initial amount | $ 473,000 | ₪ 1,668,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Percentage of share capital | 34.87% | 34.87% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Additional amount | $ 3,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
License fee income | $ 20,000 | $ 3,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Bonus amount | 51,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares issued (in Shares) | shares | 24,490 | 24,490 | 24,109 | 24,109 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares issued (in Shares) | shares | 360,297 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Dividing Amount | $ 288,238,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Outstanding share capital | $ 2,400,000 | € 2,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Additional Amount | $ 4,500 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Initial public offering share (in Shares) | shares | 3,717,473 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Warrant to purchase (in Shares) | shares | 120,192 | 5.2 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
warrants share (in Shares) | shares | 425,912 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Net issuance expenses | $ 4,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Deducting issuance | $ 2,100,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Issued and outstanding share capital, percentage | 35.94% | 46.21% | 46.21% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Warrant to purchase | $ 4.04 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Ordinary shares (in Shares) | shares | 2,824,525 | 2,824,525 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Warrant term | 3 years | 3 years | 5 years | 5 years | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Consolidated revenues | 2.18% | 2.18% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loan agreement | $ 153,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Annual interest rate percentage | 9.99% | 4% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Monthly fee | $ 16,500 | ₪ 57,500 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Securities offered amounted | ₪ | ₪ 425,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Gross proceeds percentage | 7% | 7% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Total consideration of percentage | 8% | 8% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Paid capital | $ 352,000 | $ 1,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Tradable warrants | 3,171,159 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Outstanding shares, percentage | 70% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Dividend amount | $ 1,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Dividend amount | $ 445,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Non-controlling interests | $ 153,000 | $ 226,000 | $ 219,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Internet held percentage | 10% | 10% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Total consideration amount | $ 2,625,000 | 1,613,000 | $ 2,235 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Long-term bank loan received | $ 1,500,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Long term loan | $ 6,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loan interest rate | 3.20% | 3.20% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Aggregate amount of credit line | $ 3,500,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Renewable credit line | $ 1,500,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Credit line percentage | 70% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financing rate | 3.52% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Increased Credit Line | $ 1,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Aggregate amount | 1,240,000 | $ 3,858,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Internet aggregate amount (in New Shekels) | ₪ | ₪ 4,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Tax percentage | 3.23% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loan amount | ₪ 1,000,000 | $ 914,000 | ₪ 3,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Number of shares issued (in Shares) | shares | 2,500,000 | 25,524,570 | 24,661,470 | 25,524,570 | 863,100 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Outstanding capital stock | 5% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Incentive stock options. (in Shares) | shares | 2,500,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Common Stock for Issued (in Shares) | shares | 2,500,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock-based awards (in Shares) | shares | 51,020 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Outstanding discounted percentage | 20% | 20% | 20% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Share purchase | $ 450,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Share purchase agreement | $ 120,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Purchase agreement | $ 60,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Discounted Percenatge | 20% | 20% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Consideration of shares (in Shares) | shares | 3,107,223 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Invested amount | $ 2,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Total value of the options | $ 117,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Expenses | 180,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Company lent | $ 80,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Issuance securities discount rate | 20% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Invested amount | $ 60,000 | $ 250,000 | $ 741,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Additional loan amount | $ 340,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Consideration price per share (in Dollars per share) | $ / shares | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Short term investment. | $ 6.05 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment value | 82,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Contract assets | $ 577,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Percentage of instead purchasing | 90% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Agreement amount | $ 817,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Aggregated value amount | 937,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Reflecting amount | 817,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Compensation amount | [1] | $ 685,000 | $ 649,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Other receivables | 606,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Converted shares (in Shares) | shares | 2,650,423 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Additional agreement amount | 125,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Pre-funded shares (in Shares) | shares | 4,505,718 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Aggregated gross proceeds | $ 3,500,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Common shares amount | $ 250,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loan amount | $ 250,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Percentage of annual interest | 6% | 6% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Percentage of purchased | 50% | 50% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loan interest percentage | 1% | 1% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Average quoted amount (in New Shekels) | ₪ | ₪ 1,750,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Purchased shares (in Shares) | shares | 592,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Converted shares loan (in Shares) | shares | 2,650,423 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Purchase Price [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Interest in Other Entities (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Consideration price per share (in Dollars per share) | $ / shares | $ 6.05 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Buffalo undertook purchase percentage | 90% | 90% | 90% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ClearMind Medicine, Inc.[Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Interest in Other Entities (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Public offering price per share (in Dollars per share) | $ / shares | $ 6.5 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Initial public offering [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Interest in Other Entities (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Converted shares (in Shares) | shares | 173,836 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Odysight.ai [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Interest in Other Entities (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Common stock outstanding, percentage | 27.02% | 27.02% | 27.02% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders units (in Shares) | shares | 3,294,117 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Purchase price per share (in Dollars per share) | $ / shares | $ 4.25 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Common stock par value (in Dollars per share) | $ / shares | $ 4.16 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Securities offered amounted | $ 121,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Transferred value | 937,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Eventer [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Interest in Other Entities (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Purchase agreement, description | Pursuant to the share purchase agreement, the Company invested USD 750 thousand. The share purchase agreement provides that the Company will invest an additional investment of USD 250 thousand in a second tranche (“Earn-out), subject to Eventer achieving certain post-closing EBITDA based milestones during the fiscal years 2021 through 2023, or the “Milestones”. As of June 30, 2023, the Milestones have not been achieved and the fair value of the Earn-out was determined to be immaterial. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Outstanding common stock percentage | 46.21% | 46.21% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loan agreement with Safee Cyber Technologies Inc. [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Interest in Other Entities (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loan agreement description | the Company and Eventer signed a loan agreement with Safee Cyber Technologies Inc. (“Safee”). For more details about the loan agreement, see note 4D to the Annual Financial Statements. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shrem Zilberman Group Ltd [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Interest in Other Entities (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Exercise of warrants | $ 480,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
CEO [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Interest in Other Entities (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Options to purchase (in Shares) | shares | 29,944 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Share based compensation grants [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Interest in Other Entities (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Exercise price per share (in New Shekels per share) | ₪ / shares | ₪ 0.001 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Other expenses | $ 25,000 | 91,000 | $ 78,000 | ₪ 254,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Round Robin Ltd. [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Interest in Other Entities (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Options to purchase (in Shares) | shares | 29,944 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Other expenses | 25,000 | 91,000 | $ 78,000 | ₪ 254,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Exercise price, share options granted (in New Shekels per share) | ₪ / shares | $ 0.001 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fair value grant amount | $ 473,000 | ₪ 1,668,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
SciSparc ltd [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Interest in Other Entities (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Common stock representing percentage | 49% | 49% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Issued and outstanding share capital, percentage | 1.60% | 1.60% | 1.60% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Options to purchase shares (in Shares) | shares | 150,000 | 150,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Consideration price per share (in Dollars per share) | $ / shares | $ 5.02 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Purchased additional shares (in Shares) | shares | 7,971 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sale of shares (in Shares) | shares | 49,157 | 49,157 | 49,157 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Holds shares (in Shares) | shares | 108,814 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Compensation amount | $ 130,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Jeffs’ Brands {Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Interest in Other Entities (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares issued (in Shares) | shares | 247,415 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
IPO [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Interest in Other Entities (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Common stock par value (in Dollars per share) | $ / shares | $ 4.04 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Warrant to purchase | $ 2.02 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Price per share | 125% | 125% | 125% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Gix internet [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Interest in Other Entities (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Outstanding share capital | 42.25% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loans | ₪ | ₪ 3,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loan interest rate | 2.92% | 2.92% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Gix Media [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Interest in Other Entities (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Outstanding shares, percentage | 76% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Percentage on shares issued | 76% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Internet held percentage | 10% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Provide for line of credit | $ 3,500,000 | $ 3,500,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loans | $ 6,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loan interest rate | 4.12% | 4.12% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ViewBix Inc. [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Interest in Other Entities (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Outstanding shares, percentage | 100% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Gix [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Interest in Other Entities (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Aggregate amount | ₪ | ₪ 12,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Polyrizon [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Interest in Other Entities (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Development services amount | $ 2,500,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, percentage | 37.03% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Aggregate proceeds amount | $ 203,000 | $ 110,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Invested amount | $ 400,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Equity financing amount | $ 753,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Parazero Technologies Ltd [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Interest in Other Entities (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Percentage of share capital | 100% | 100% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Total consideration amount | $ 4,335,000,000 | $ 6,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Aggregate amount | $ 625,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loan agreement amount | $ 302,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Purchased shares (in Shares) | shares | 674,362 | 674,362 | 674,362 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Issued and outstanding shares, percentage | 40.35% | 40.35% | 40.35% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Received amount | $ 18,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Received amount | $ 1,500,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment amount | $ 521,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Parazero withdrew amount | $ 745,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Holdings issued and outstanding shares percentage | 19.90% | 19.90% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Elbit Imaging Ltd [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Interest in Other Entities (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Outstanding shares, percentage | 40.22% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Revoltz [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Interest in Other Entities (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Aggregate amount | $ 500,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Pre-money valuation | 10,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Revoltz Ltd.[Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Interest in Other Entities (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Issued and outstanding share capital, percentage | 19.99% | 19.99% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Consideration ordinary shares (in Shares) | shares | 19,990 | 19,990 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Buffalo Investments Ltd. [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Interest in Other Entities (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Options to purchase shares (in Shares) | shares | 150,000 | 150,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Buffalo Agreement [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Interest in Other Entities (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Consideration ordinary shares (in Shares) | shares | 150,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Warrant per share (in Dollars per share) | $ / shares | $ 0.72 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Paid transactions | $ 72,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Purchase percentage | 85% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Jeffs’ Brands IPO [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Interest in Other Entities (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Contract assets | 577,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fuel Doctor Holdings Inc. [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Interest in Other Entities (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Total consideration amount | $ 262,500 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Purchased shares (in Shares) | shares | 90,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Issued and outstanding shares, percentage | 35.06% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Share issued (in Shares) | shares | 827,543,253 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Percentage of common stock equal | 76.25% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Percentage of issued and outstanding share capital | 67% | 67% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Laminera Flow Optimization Ltd [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Interest in Other Entities (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fair value | $ 400,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Invested amount | $ 300,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Issued and outstanding shares, percentage | 11.18% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Share issued (in Shares) | shares | 324,675 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Percentage of investment | 19.70% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loan agreement | $ 100,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Bear annual interest percentage | 8% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Cortex Media Group Ltd [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Interest in Other Entities (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Subscription agreement description | the Company entered into a subscription agreement with Clearmind, for a private placement in which Clearmind raised approximately CAD 1.6 million (USD 1.25 million) (“Subscription Agreement”). Pursuant to the Subscription Agreement Clearmind issued to the Company 1,987,344 units, at a subscription price of CAD 0.80 (USD 0.63) per unit. Each unit is comprised of one Common Share and one warrant to purchase one Common Share of Clearmind. Each warrant will be exercisable for a period of 18 months into one additional Common Share at an exercise price of CAD 2.00 per share. On August 14, 2023, the warrants expired.CAD 960 thousand (USD 750 thousand) of the investment amount was paid by the Company in cash and CAD 640 thousand (USD 500 thousand) of the investment amount was paid through the issuance of the Company’s ordinary shares, at a price per share of USD 1.20. The Company issued to Clearmind 416,666 shares. The Company’s holdings in Clearmind’s issued and outstanding shares were 5.02%. | the Company entered into a subscription agreement with Clearmind, for a private placement in which Clearmind raised approximately CAD 1.6 million (USD 1.25 million) (“Subscription Agreement”). Pursuant to the Subscription Agreement Clearmind issued to the Company 1,987,344 units, at a subscription price of CAD 0.80 (USD 0.63) per unit. Each unit is comprised of one Common Share and one warrant to purchase one Common Share of Clearmind. Each warrant will be exercisable for a period of 18 months into one additional Common Share at an exercise price of CAD 2.00 per share. On August 14, 2023, the warrants expired.CAD 960 thousand (USD 750 thousand) of the investment amount was paid by the Company in cash and CAD 640 thousand (USD 500 thousand) of the investment amount was paid through the issuance of the Company’s ordinary shares, at a price per share of USD 1.20. The Company issued to Clearmind 416,666 shares. The Company’s holdings in Clearmind’s issued and outstanding shares were 5.02%. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ClearMind Medicine, Inc.[Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Interest in Other Entities (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares received (in Shares) | shares | 44,829 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Public offering shares (in Shares) | shares | 1,153,847 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Aggregate gross proceeds | $ 7,500,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
GERD IP Inc [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Interest in Other Entities (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Issued and outstanding shares, percentage | 2.64% | 2.64% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Received compensation | 1,300,000 | $ 1,300,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Net amount received | 631,000 | $ 631,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Safee Cyber Technologies Ltd. [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Interest in Other Entities (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Invested additional amount | $ 400,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fully diluted shares capital, percentage | 2.35% | 2.35% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Subsequent Event [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Interest in Other Entities (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Remaining percentage | 18.45% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Issued and outstanding shares, percentage | 36% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Share issued (in Shares) | shares | 169,920 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loan amount | $ 785,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Subsequent Event [Member] | Initial public offering [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Interest in Other Entities (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Aggregated gross proceeds | $ 7,800,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Bottom of range [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Interest in Other Entities (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Exchange Shares Percentage | 2.97% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Top of range [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Interest in Other Entities (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Exchange Shares Percentage | 4.99% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Eventer [Member] | CEO [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Interest in Other Entities (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Options to purchase (in Shares) | shares | 29,944 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Hydreight Technologies Inc.[Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Interest in Other Entities (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares issued (in Shares) | shares | 309,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares received (in Shares) | shares | 307,000 | 307,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Viewbix Inc [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Interest in Other Entities (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares issued (in Shares) | shares | 77,980 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
SciSparc ltd [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Interest in Other Entities (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares issued (in Shares) | shares | 84,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares received (in Shares) | shares | 63,000 | 63,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ClearMind Medicine, Inc.[Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Interest in Other Entities (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares issued (in Shares) | shares | 36,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Colugo Systems Ltd [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Interest in Other Entities (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares issued (in Shares) | shares | 31,250 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Metagramm Software Ltd [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Interest in Other Entities (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Initial equity percentage | 19.90% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Lent amount | $ 167,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Percentage of holding increase | 31.25% | 31.25% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
A.I Systems [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Interest in Other Entities (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fair value | $ 894,000 | ₪ 30,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loan amount | ₪ | ₪ 3,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Issued and outstanding shares, percentage | 36% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fair value of the loan | $ 940,000 | ₪ 3,307,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
IPO [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Interest in Other Entities (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Consideration amount | $ 500,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Warrants [member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Interest in Other Entities (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares received (in Shares) | shares | 2,241 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Pre-funded shares (in Shares) | shares | 4,505,718 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Warrants [member] | Algomizer [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Interest in Other Entities (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Number of warrants issued (in Shares) | shares | 185,873 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Warrants A [Member] | Odysight.ai [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Interest in Other Entities (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Net issuance expenses | $ 13,400,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
[1]As of June 30, 2023, these balances include compensation to key management personnel of the Company, Eventer, Gix Internet, Fuel Doctor and Jeffs’ Brands. |
Interest in Other Entities (D_2
Interest in Other Entities (Details) - Schedule of General Information | 6 Months Ended | 12 Months Ended |
Jun. 30, 2023 | Dec. 31, 2022 | |
Jeffs’ Brands [Member] | ||
Interest in Other Entities (Details) - Schedule of General Information [Line Items] | ||
Main place of the business | Israel | |
Ownership rights held by the Company | 34.87% | |
Ownership rights held by non- controlling interests | 65.13% | |
Eventer [Member] | ||
Interest in Other Entities (Details) - Schedule of General Information [Line Items] | ||
Main place of the business | Israel | |
Ownership rights held by the Company | 46.21% | |
Ownership rights held by non- controlling interests | 53.79% | |
Fuel Doctor [Member] | ||
Interest in Other Entities (Details) - Schedule of General Information [Line Items] | ||
Main place of the business | USA | |
Ownership rights held by the Company | 67% | |
Ownership rights held by non- controlling interests | 33% | |
GERD IP [Member] | ||
Interest in Other Entities (Details) - Schedule of General Information [Line Items] | ||
Main place of the business | USA | |
Ownership rights held by the Company | 90% | |
Ownership rights held by non- controlling interests | 10% | |
Gix Internet [Member] | ||
Interest in Other Entities (Details) - Schedule of General Information [Line Items] | ||
Main place of the business | Israel | |
Ownership rights held by the Company | 42.25% | |
Ownership rights held by non- controlling interests | 57.75% | |
Jeffs’ Brands [Member] | ||
Interest in Other Entities (Details) - Schedule of General Information [Line Items] | ||
Main place of the business | Israel | |
Ownership rights held by the Company | 35.94% | |
Ownership rights held by non- controlling interests | 64.06% | |
Eventer [Member] | ||
Interest in Other Entities (Details) - Schedule of General Information [Line Items] | ||
Main place of the business | Israel | |
Ownership rights held by the Company | 46.21% | |
Ownership rights held by non- controlling interests | 53.79% | |
Charging Robotics [Member] | ||
Interest in Other Entities (Details) - Schedule of General Information [Line Items] | ||
Main place of the business | Israel | |
Ownership rights held by the Company | 100% | |
Ownership rights held by non- controlling interests | ||
GERD IP [Member] | ||
Interest in Other Entities (Details) - Schedule of General Information [Line Items] | ||
Main place of the business | USA | |
Ownership rights held by the Company | 90% | |
Ownership rights held by non- controlling interests | 10% | |
Gix Internet [Member] | ||
Interest in Other Entities (Details) - Schedule of General Information [Line Items] | ||
Main place of the business | Israel | |
Ownership rights held by the Company | 42.25% | |
Ownership rights held by non- controlling interests | 57.75% |
Interest in Other Entities (D_3
Interest in Other Entities (Details) - Schedule of Statement of Financial Position - Statement of Financial Position [Member] - USD ($) $ in Thousands | Jun. 30, 2023 | Dec. 31, 2022 | |
Eventer Ltd. [Member] | |||
Interest in Other Entities (Details) - Schedule of Statement of Financial Position [Line Items] | |||
Current assets | [1] | $ 2,044 | $ 1,829 |
Non-current assets | [1] | 1,315 | 1,379 |
Current liabilities | [1] | 3,234 | 2,766 |
Non-current liabilities | [1] | 476 | |
Equity (Deficit) | [1] | 125 | (34) |
Jeffs’ Brands Ltd. [Member] | |||
Interest in Other Entities (Details) - Schedule of Statement of Financial Position [Line Items] | |||
Current assets | 5,457 | 11,033 | |
Non-current assets | 9,622 | 4,743 | |
Current liabilities | 5,239 | 5,133 | |
Non-current liabilities | 88 | 98 | |
Equity (Deficit) | 9,752 | 10,545 | |
Gix internet [Member] | |||
Interest in Other Entities (Details) - Schedule of Statement of Financial Position [Line Items] | |||
Current assets | [1] | 22,701 | 26,481 |
Non-current assets | [1] | 15,367 | 16,549 |
Current liabilities | [1] | 27,692 | 29,529 |
Non-current liabilities | [1] | 4,069 | 4,127 |
Equity (Deficit) | [1] | 6,307 | 9,374 |
Equity attributable to Gix Internet shareholders | [1] | 2,517 | 4,804 |
Non-controlling interests | [1] | $ 3,790 | $ 4,570 |
[1] Translated according to the exchange rate at the date of each statement of financial position. |
Interest in Other Entities (D_4
Interest in Other Entities (Details) - Schedule of Comprehensive Income - USD ($) $ in Thousands | 4 Months Ended | 6 Months Ended | |
Jun. 30, 2022 | Jun. 30, 2023 | Jun. 30, 2022 | |
Eventer [Member] | |||
Interest in Other Entities (Details) - Schedule of Comprehensive Income [Line Items] | |||
Revenues | $ 1,498 | $ 1,472 | |
Net profit (loss) for the period | 111 | (587) | |
Jeffs’ Brands Ltd.[Member] | |||
Interest in Other Entities (Details) - Schedule of Comprehensive Income [Line Items] | |||
Revenues | 3,871 | 2,343 | |
Net profit (loss) for the period | (1,079) | $ (1,526) | |
Gix Internet Ltd [Member] | |||
Interest in Other Entities (Details) - Schedule of Comprehensive Income [Line Items] | |||
Revenues | $ 31,144 | 48,016 | |
Net profit (loss) for the period | $ 164 | $ (122) |
Interest in Other Entities (D_5
Interest in Other Entities (Details) - Schedule of Cash Flows - USD ($) $ in Thousands | 4 Months Ended | 6 Months Ended | ||
Jun. 30, 2022 | Jun. 30, 2023 | Jun. 30, 2022 | ||
Eventer Ltd. [Member] | ||||
Interest in Other Entities (Details) - Schedule of Cash Flows [Line Items] | ||||
Cash flow used in operating activities | [1] | $ 199 | $ 1,235 | |
Cash flow used in investing activities | [1] | (6) | (6) | |
Cash flow from (used in) financing activities | [1] | (146) | ||
Gain (losses) from exchange differences on cash and cash equivalents | [1] | (79) | (288) | |
Net increase (decrease) in cash and cash equivalents | [1] | 114 | 795 | |
Jeffs’ Brands Ltd. [Member] | ||||
Interest in Other Entities (Details) - Schedule of Cash Flows [Line Items] | ||||
Cash flow used in operating activities | (749) | (1,054) | ||
Cash flow used in investing activities | (4,998) | (3) | ||
Cash flow from (used in) financing activities | (119) | 731 | ||
Net increase (decrease) in cash and cash equivalents | (5,866) | $ (326) | ||
Gix internet [Member] | ||||
Interest in Other Entities (Details) - Schedule of Cash Flows [Line Items] | ||||
Cash flow used in operating activities | [2] | $ 989 | 993 | |
Cash flow used in investing activities | [2] | (9) | (8) | |
Cash flow from (used in) financing activities | [2] | 1,661 | (1,851) | |
Gain (losses) from exchange differences on cash and cash equivalents | [2] | 51 | 109 | |
Net increase (decrease) in cash and cash equivalents | [2] | $ 2,692 | $ (757) | |
[1] Translated according to the average exchange rates for each period. translated at average exchange rates for each period. |
Interest in Other Entities (D_6
Interest in Other Entities (Details) - Schedule of Non-Controlling Interest - Non-controlling interests [member] - USD ($) $ in Thousands | Jun. 30, 2023 | Dec. 31, 2022 |
Interest in Other Entities (Details) - Schedule of Non-Controlling Interest [Line Items] | ||
Balance of non-controlling interests | $ 12,684 | $ 15,548 |
Eventer [Member] | ||
Interest in Other Entities (Details) - Schedule of Non-Controlling Interest [Line Items] | ||
Balance of non-controlling interests | 860 | 721 |
Jeffs’ Brands [Member] | ||
Interest in Other Entities (Details) - Schedule of Non-Controlling Interest [Line Items] | ||
Balance of non-controlling interests | 6,727 | 7,199 |
Charging Robotics [Member] | ||
Interest in Other Entities (Details) - Schedule of Non-Controlling Interest [Line Items] | ||
Balance of non-controlling interests | 91 | |
Gix Internet [Member] | ||
Interest in Other Entities (Details) - Schedule of Non-Controlling Interest [Line Items] | ||
Balance of non-controlling interests | 4,724 | 7,480 |
GERD IP [Member] | ||
Interest in Other Entities (Details) - Schedule of Non-Controlling Interest [Line Items] | ||
Balance of non-controlling interests | 57 | 57 |
Fuel Doctor [Member] | ||
Interest in Other Entities (Details) - Schedule of Non-Controlling Interest [Line Items] | ||
Balance of non-controlling interests | $ 316 |
Interest in Other Entities (D_7
Interest in Other Entities (Details) - Schedule of Profit (Loss) Attributed to Non-Controlling Interest - USD ($) $ in Thousands | 6 Months Ended | |
Jun. 30, 2023 | Jun. 30, 2022 | |
Interest in Other Entities (Details) - Schedule of Profit (Loss) Attributed to Non-Controlling Interest [Line Items] | ||
Profit (Loss) attributed to non-controlling interests | $ (1,336) | $ (1,158) |
Eventer [Member] | ||
Interest in Other Entities (Details) - Schedule of Profit (Loss) Attributed to Non-Controlling Interest [Line Items] | ||
Profit (Loss) attributed to non-controlling interests | 88 | (307) |
Jeffs’ Brands [Member] | ||
Interest in Other Entities (Details) - Schedule of Profit (Loss) Attributed to Non-Controlling Interest [Line Items] | ||
Profit (Loss) attributed to non-controlling interests | (661) | (793) |
Gix Internet [Member] | ||
Interest in Other Entities (Details) - Schedule of Profit (Loss) Attributed to Non-Controlling Interest [Line Items] | ||
Profit (Loss) attributed to non-controlling interests | (668) | (65) |
GERD IP [Member] | ||
Interest in Other Entities (Details) - Schedule of Profit (Loss) Attributed to Non-Controlling Interest [Line Items] | ||
Profit (Loss) attributed to non-controlling interests | 7 | |
Fuel Doctor [Member] | ||
Interest in Other Entities (Details) - Schedule of Profit (Loss) Attributed to Non-Controlling Interest [Line Items] | ||
Profit (Loss) attributed to non-controlling interests | $ (95) |
Interest in Other Entities (D_8
Interest in Other Entities (Details) - Schedule of Total Investment According to the Equity Method - USD ($) $ in Thousands | Jun. 30, 2023 | Dec. 31, 2022 |
Interest in Other Entities (Details) - Schedule of Total Investment According to the Equity Method [Line Items] | ||
Total | $ 5,454 | $ 11,892 |
Odysight.ai [Member] | ||
Interest in Other Entities (Details) - Schedule of Total Investment According to the Equity Method [Line Items] | ||
Total | 9,375 | |
Polyrizon [Member] | ||
Interest in Other Entities (Details) - Schedule of Total Investment According to the Equity Method [Line Items] | ||
Total | 592 | 976 |
Laminera [Member] | ||
Interest in Other Entities (Details) - Schedule of Total Investment According to the Equity Method [Line Items] | ||
Total | 1,142 | 1,176 |
Polyrizon [Member] | ||
Interest in Other Entities (Details) - Schedule of Total Investment According to the Equity Method [Line Items] | ||
Total | 643 | 214 |
SciSparc Nutraceuticals [Member] | ||
Interest in Other Entities (Details) - Schedule of Total Investment According to the Equity Method [Line Items] | ||
Total | 2,944 | |
Revoltz [Member] | ||
Interest in Other Entities (Details) - Schedule of Total Investment According to the Equity Method [Line Items] | ||
Total | $ 133 | $ 151 |
Interest in Other Entities (D_9
Interest in Other Entities (Details) - Schedule of Summarizes the Total Loss From Investments Accounted for Using the Equity Method - USD ($) $ in Thousands | 6 Months Ended | |
Jun. 30, 2023 | Jun. 30, 2022 | |
Interest in Other Entities (Details) - Schedule of Summarizes the Total Loss From Investments Accounted for Using the Equity Method [Line Items] | ||
Total loss from investments | $ 1,238 | $ 1,910 |
Odysight.ai [Member] | ||
Interest in Other Entities (Details) - Schedule of Summarizes the Total Loss From Investments Accounted for Using the Equity Method [Line Items] | ||
Total loss from investments | 655 | 1,073 |
Gix Internet [Member] | ||
Interest in Other Entities (Details) - Schedule of Summarizes the Total Loss From Investments Accounted for Using the Equity Method [Line Items] | ||
Total loss from investments | 215 | |
Parazero [Member] | ||
Interest in Other Entities (Details) - Schedule of Summarizes the Total Loss From Investments Accounted for Using the Equity Method [Line Items] | ||
Total loss from investments | 384 | 295 |
Laminera [Member] | ||
Interest in Other Entities (Details) - Schedule of Summarizes the Total Loss From Investments Accounted for Using the Equity Method [Line Items] | ||
Total loss from investments | 34 | 81 |
Polyrizon [Member] | ||
Interest in Other Entities (Details) - Schedule of Summarizes the Total Loss From Investments Accounted for Using the Equity Method [Line Items] | ||
Total loss from investments | 65 | 159 |
Elbit Imaging [Member] | ||
Interest in Other Entities (Details) - Schedule of Summarizes the Total Loss From Investments Accounted for Using the Equity Method [Line Items] | ||
Total loss from investments | 78 | |
SciSparc Nutraceuticals [Member] | ||
Interest in Other Entities (Details) - Schedule of Summarizes the Total Loss From Investments Accounted for Using the Equity Method [Line Items] | ||
Total loss from investments | 89 | |
Revoltz [Member] | ||
Interest in Other Entities (Details) - Schedule of Summarizes the Total Loss From Investments Accounted for Using the Equity Method [Line Items] | ||
Total loss from investments | $ 11 | $ 9 |
Interest in Other Entities (_10
Interest in Other Entities (Details) - Schedule of Summarize the Company’s Rights in Share Capital and Voting Rights | 6 Months Ended | 12 Months Ended |
Jun. 30, 2023 | Dec. 31, 2022 | |
Parazero [Member] | ||
Interest in Other Entities (Details) - Schedule of Summarize the Company’s Rights in Share Capital and Voting Rights [Line Items] | ||
Main place of the business | Israel | Israel |
Company rights in share capital and voting rights | 40.35% | 40.35% |
Laminera [Member] | ||
Interest in Other Entities (Details) - Schedule of Summarize the Company’s Rights in Share Capital and Voting Rights [Line Items] | ||
Main place of the business | Israel | Israel |
Company rights in share capital and voting rights | 19.70% | 19.70% |
Polyrizon [Member] | ||
Interest in Other Entities (Details) - Schedule of Summarize the Company’s Rights in Share Capital and Voting Rights [Line Items] | ||
Main place of the business | Israel | Israel |
Company rights in share capital and voting rights | 40.22% | 37.03% |
Revoltz [Member] | ||
Interest in Other Entities (Details) - Schedule of Summarize the Company’s Rights in Share Capital and Voting Rights [Line Items] | ||
Main place of the business | Israel | Israel |
Company rights in share capital and voting rights | 19.90% | 19.90% |
SciSparc Nutraceuticals [Member] | ||
Interest in Other Entities (Details) - Schedule of Summarize the Company’s Rights in Share Capital and Voting Rights [Line Items] | ||
Main place of the business | USA | |
Company rights in share capital and voting rights | 49.90% | |
Odysight.ai [Member] | ||
Interest in Other Entities (Details) - Schedule of Summarize the Company’s Rights in Share Capital and Voting Rights [Line Items] | ||
Main place of the business | Israel | |
Company rights in share capital and voting rights | 27.02% | |
Fuel Doctor [Member] | ||
Interest in Other Entities (Details) - Schedule of Summarize the Company’s Rights in Share Capital and Voting Rights [Line Items] | ||
Main place of the business | Israel | |
Company rights in share capital and voting rights | 28.63% |
Interest in Other Entities (_11
Interest in Other Entities (Details) - Schedule of Activity in Investment Account - USD ($) $ in Thousands | 2 Months Ended | 3 Months Ended | 6 Months Ended |
Feb. 23, 2023 | Mar. 21, 2023 | Jun. 30, 2023 | |
ScoutCam [Member] | |||
Interest in Other Entities (Details) - Schedule of Activity in Investment Account [Line Items] | |||
Beginning balance | $ 9,375 | $ 9,375 | $ 9,375 |
Loss for the period | (655) | ||
Ending balance | 8,720 | ||
Loss as a result of transition to FVTPL | (2,946) | ||
Fair value of the investment as of March 21, 2023 | 5,774 | ||
SciSparc Nutraceuticals [Member] | |||
Interest in Other Entities (Details) - Schedule of Activity in Investment Account [Line Items] | |||
Beginning balance | |||
Additional purchase | 3,033 | ||
Loss for the period | (89) | ||
Ending balance | 2,944 | ||
Polyrizon [Member] | |||
Interest in Other Entities (Details) - Schedule of Activity in Investment Account [Line Items] | |||
Beginning balance | 214 | 214 | 214 |
Additional purchase | 180 | ||
Safe conversion into shares | 314 | ||
Loss for the period | (65) | ||
Ending balance | 643 | ||
Parazero [Member] | |||
Interest in Other Entities (Details) - Schedule of Activity in Investment Account [Line Items] | |||
Beginning balance | 976 | 976 | 976 |
Loss for the period | (384) | ||
Ending balance | 592 | ||
Laminera [Member] | |||
Interest in Other Entities (Details) - Schedule of Activity in Investment Account [Line Items] | |||
Beginning balance | $ 1,176 | $ 1,176 | 1,176 |
Loss for the period | (20) | ||
Excess cost amortization | (14) | ||
Ending balance | $ 1,142 |
Interest in Other Entities (_12
Interest in Other Entities (Details) - Schedule of Short Term Loans - Short Term Loans [Member] - USD ($) $ in Thousands | 6 Months Ended | 12 Months Ended |
Jun. 30, 2023 | Dec. 31, 2022 | |
Schedule of short term loans [Abstract] | ||
Short term bank loans | $ 5,973 | $ 5,025 |
Current maturities of long-term loans | 1,879 | 1,500 |
Total consideration | $ 7,852 | $ 6,525 |
Interest in Other Entities (_13
Interest in Other Entities (Details) - Schedule of Long Term Loans - USD ($) $ in Thousands | 6 Months Ended | 12 Months Ended |
Jun. 30, 2023 | Dec. 31, 2022 | |
Schedule Of Long Term Loans Abstract | ||
Long term bank loans | $ 3,128 | $ 2,881 |
Total long term bank loans | $ 3,128 | $ 2,881 |
Financial Instruments (Details)
Financial Instruments (Details) | 6 Months Ended |
Jun. 30, 2023 $ / shares | |
Disclosure of detailed information about financial instruments [line items] | |
Share price (in Dollars per share) | $ 0.75 |
Expected volatility | 100% |
Exercise price (in Dollars per share) | $ 2.02 |
Risk-free interest rate | 5.40% |
Expected life term | 4 years 4 months 28 days |
Percentage of weighted average cost of capital | 23.20% |
Financial Instruments (Detail_2
Financial Instruments (Details) - Schedule of Fair Value Financial Assets - USD ($) $ in Thousands | Jun. 30, 2023 | Dec. 31, 2022 |
Investments in shares, warrants and SAFEs [member] | ||
Disclosure of financial assets [line items] | ||
Financial assets | $ 3,436 | $ 5,369 |
Investments in shares, warrants and SAFEs [member] | Safo shares [Member] | ||
Disclosure of financial assets [line items] | ||
Financial assets | 8 | 10 |
Investments in shares, warrants and SAFEs [member] | Maris shares [Member] | ||
Disclosure of financial assets [line items] | ||
Financial assets | 110 | 84 |
Investments in shares, warrants and SAFEs [member] | Maris warrants [Member] | ||
Disclosure of financial assets [line items] | ||
Financial assets | 16 | 13 |
Investments in shares, warrants and SAFEs [member] | Tondo shares [Member] | ||
Disclosure of financial assets [line items] | ||
Financial assets | 101 | 97 |
Investments in shares, warrants and SAFEs [member] | Safee shares [Member] | ||
Disclosure of financial assets [line items] | ||
Financial assets | 400 | 400 |
Investments in shares, warrants and SAFEs [member] | SciSparc shares [Member] | ||
Disclosure of financial assets [line items] | ||
Financial assets | 233 | 659 |
Investments in shares, warrants and SAFEs [member] | Polyrizon warrants [Member] | ||
Disclosure of financial assets [line items] | ||
Financial assets | 117 | 399 |
Investments in shares, warrants and SAFEs [member] | Polyrizon SAFEs [Member] | ||
Disclosure of financial assets [line items] | ||
Financial assets | 302 | |
Investments in shares, warrants and SAFEs [member] | Elbit Imaging shares [Member] | ||
Disclosure of financial assets [line items] | ||
Financial assets | 578 | 613 |
Investments in shares, warrants and SAFEs [member] | Hydreight Technologies shares [Member] | ||
Disclosure of financial assets [line items] | ||
Financial assets | 109 | |
Investments in shares, warrants and SAFEs [member] | Clearmind warrants [Member] | ||
Disclosure of financial assets [line items] | ||
Financial assets | 4 | 4 |
Investments in shares, warrants and SAFEs [member] | A.I Systems shares [Member] | ||
Disclosure of financial assets [line items] | ||
Financial assets | 47 | |
Investments in shares, warrants and SAFEs [member] | Clearmind shares [Member] | ||
Disclosure of financial assets [line items] | ||
Financial assets | 90 | 594 |
Investments in shares, warrants and SAFEs [member] | Metagramm shares [Member] | ||
Disclosure of financial assets [line items] | ||
Financial assets | 250 | |
Investments in shares, warrants and SAFEs [member] | Colugo shares [Member] | ||
Disclosure of financial assets [line items] | ||
Financial assets | 400 | 400 |
Investments in shares, warrants and SAFEs [member] | Parazero -SAFE [Member] | ||
Disclosure of financial assets [line items] | ||
Financial assets | 520 | 520 |
Investments in shares, warrants and SAFEs [member] | Bubbles shares [Member] | ||
Disclosure of financial assets [line items] | ||
Financial assets | 106 | 151 |
Investments in shares, warrants and SAFEs [member] | Automax warrants [Member] | ||
Disclosure of financial assets [line items] | ||
Financial assets | 6 | 9 |
Investments in shares, warrants and SAFEs [member] | Automax shares [Member] | ||
Disclosure of financial assets [line items] | ||
Financial assets | 341 | 1,114 |
Investments in shares, warrants and SAFEs [member] | Level 1 [Member] | ||
Disclosure of financial assets [line items] | ||
Financial assets | 1,729 | 3,331 |
Investments in shares, warrants and SAFEs [member] | Level 1 [Member] | Safo shares [Member] | ||
Disclosure of financial assets [line items] | ||
Financial assets | 8 | 10 |
Investments in shares, warrants and SAFEs [member] | Level 1 [Member] | Maris shares [Member] | ||
Disclosure of financial assets [line items] | ||
Financial assets | 110 | 84 |
Investments in shares, warrants and SAFEs [member] | Level 1 [Member] | Maris warrants [Member] | ||
Disclosure of financial assets [line items] | ||
Financial assets | ||
Investments in shares, warrants and SAFEs [member] | Level 1 [Member] | Tondo shares [Member] | ||
Disclosure of financial assets [line items] | ||
Financial assets | 101 | 97 |
Investments in shares, warrants and SAFEs [member] | Level 1 [Member] | Safee shares [Member] | ||
Disclosure of financial assets [line items] | ||
Financial assets | ||
Investments in shares, warrants and SAFEs [member] | Level 1 [Member] | SciSparc shares [Member] | ||
Disclosure of financial assets [line items] | ||
Financial assets | 233 | 659 |
Investments in shares, warrants and SAFEs [member] | Level 1 [Member] | Polyrizon warrants [Member] | ||
Disclosure of financial assets [line items] | ||
Financial assets | ||
Investments in shares, warrants and SAFEs [member] | Level 1 [Member] | Polyrizon SAFEs [Member] | ||
Disclosure of financial assets [line items] | ||
Financial assets | ||
Investments in shares, warrants and SAFEs [member] | Level 1 [Member] | Elbit Imaging shares [Member] | ||
Disclosure of financial assets [line items] | ||
Financial assets | 578 | 613 |
Investments in shares, warrants and SAFEs [member] | Level 1 [Member] | Hydreight Technologies shares [Member] | ||
Disclosure of financial assets [line items] | ||
Financial assets | 109 | |
Investments in shares, warrants and SAFEs [member] | Level 1 [Member] | Clearmind warrants [Member] | ||
Disclosure of financial assets [line items] | ||
Financial assets | ||
Investments in shares, warrants and SAFEs [member] | Level 1 [Member] | A.I Systems shares [Member] | ||
Disclosure of financial assets [line items] | ||
Financial assets | 47 | |
Investments in shares, warrants and SAFEs [member] | Level 1 [Member] | Clearmind shares [Member] | ||
Disclosure of financial assets [line items] | ||
Financial assets | 90 | 594 |
Investments in shares, warrants and SAFEs [member] | Level 1 [Member] | Metagramm shares [Member] | ||
Disclosure of financial assets [line items] | ||
Financial assets | ||
Investments in shares, warrants and SAFEs [member] | Level 1 [Member] | Colugo shares [Member] | ||
Disclosure of financial assets [line items] | ||
Financial assets | ||
Investments in shares, warrants and SAFEs [member] | Level 1 [Member] | Parazero -SAFE [Member] | ||
Disclosure of financial assets [line items] | ||
Financial assets | ||
Investments in shares, warrants and SAFEs [member] | Level 1 [Member] | Bubbles shares [Member] | ||
Disclosure of financial assets [line items] | ||
Financial assets | 106 | 151 |
Investments in shares, warrants and SAFEs [member] | Level 1 [Member] | Automax warrants [Member] | ||
Disclosure of financial assets [line items] | ||
Financial assets | 6 | 9 |
Investments in shares, warrants and SAFEs [member] | Level 1 [Member] | Automax shares [Member] | ||
Disclosure of financial assets [line items] | ||
Financial assets | 341 | 1,114 |
Investments in shares, warrants and SAFEs [member] | Level 3 [Member] | ||
Disclosure of financial assets [line items] | ||
Financial assets | 1,707 | 2,038 |
Investments in shares, warrants and SAFEs [member] | Level 3 [Member] | Safo shares [Member] | ||
Disclosure of financial assets [line items] | ||
Financial assets | ||
Investments in shares, warrants and SAFEs [member] | Level 3 [Member] | Maris shares [Member] | ||
Disclosure of financial assets [line items] | ||
Financial assets | ||
Investments in shares, warrants and SAFEs [member] | Level 3 [Member] | Maris warrants [Member] | ||
Disclosure of financial assets [line items] | ||
Financial assets | 16 | 13 |
Investments in shares, warrants and SAFEs [member] | Level 3 [Member] | Tondo shares [Member] | ||
Disclosure of financial assets [line items] | ||
Financial assets | ||
Investments in shares, warrants and SAFEs [member] | Level 3 [Member] | Safee shares [Member] | ||
Disclosure of financial assets [line items] | ||
Financial assets | 400 | 400 |
Investments in shares, warrants and SAFEs [member] | Level 3 [Member] | SciSparc shares [Member] | ||
Disclosure of financial assets [line items] | ||
Financial assets | ||
Investments in shares, warrants and SAFEs [member] | Level 3 [Member] | Polyrizon warrants [Member] | ||
Disclosure of financial assets [line items] | ||
Financial assets | 117 | 399 |
Investments in shares, warrants and SAFEs [member] | Level 3 [Member] | Polyrizon SAFEs [Member] | ||
Disclosure of financial assets [line items] | ||
Financial assets | 302 | |
Investments in shares, warrants and SAFEs [member] | Level 3 [Member] | Elbit Imaging shares [Member] | ||
Disclosure of financial assets [line items] | ||
Financial assets | ||
Investments in shares, warrants and SAFEs [member] | Level 3 [Member] | Hydreight Technologies shares [Member] | ||
Disclosure of financial assets [line items] | ||
Financial assets | ||
Investments in shares, warrants and SAFEs [member] | Level 3 [Member] | Clearmind warrants [Member] | ||
Disclosure of financial assets [line items] | ||
Financial assets | 4 | 4 |
Investments in shares, warrants and SAFEs [member] | Level 3 [Member] | A.I Systems shares [Member] | ||
Disclosure of financial assets [line items] | ||
Financial assets | ||
Investments in shares, warrants and SAFEs [member] | Level 3 [Member] | Clearmind shares [Member] | ||
Disclosure of financial assets [line items] | ||
Financial assets | ||
Investments in shares, warrants and SAFEs [member] | Level 3 [Member] | Metagramm shares [Member] | ||
Disclosure of financial assets [line items] | ||
Financial assets | 250 | |
Investments in shares, warrants and SAFEs [member] | Level 3 [Member] | Colugo shares [Member] | ||
Disclosure of financial assets [line items] | ||
Financial assets | 400 | 400 |
Investments in shares, warrants and SAFEs [member] | Level 3 [Member] | Parazero -SAFE [Member] | ||
Disclosure of financial assets [line items] | ||
Financial assets | 520 | 520 |
Investments in shares, warrants and SAFEs [member] | Level 3 [Member] | Bubbles shares [Member] | ||
Disclosure of financial assets [line items] | ||
Financial assets | ||
Investments in shares, warrants and SAFEs [member] | Level 3 [Member] | Automax warrants [Member] | ||
Disclosure of financial assets [line items] | ||
Financial assets | ||
Investments in shares, warrants and SAFEs [member] | Level 3 [Member] | Automax shares [Member] | ||
Disclosure of financial assets [line items] | ||
Financial assets | ||
Loans to associates and others [member] | ||
Disclosure of financial assets [line items] | ||
Financial assets | 1,036 | 1,002 |
Loans to associates and others [member] | Loan to Revoltz [Member] | ||
Disclosure of financial assets [line items] | ||
Financial assets | 62 | 62 |
Loans to associates and others [member] | Loan to Polyrizon [Member] | ||
Disclosure of financial assets [line items] | ||
Financial assets | 80 | |
Loans to associates and others [member] | Loan to A.I Systems [Member] | ||
Disclosure of financial assets [line items] | ||
Financial assets | 894 | 940 |
Loans to associates and others [member] | Level 1 [Member] | ||
Disclosure of financial assets [line items] | ||
Financial assets | ||
Loans to associates and others [member] | Level 1 [Member] | Loan to Revoltz [Member] | ||
Disclosure of financial assets [line items] | ||
Financial assets | ||
Loans to associates and others [member] | Level 1 [Member] | Loan to Polyrizon [Member] | ||
Disclosure of financial assets [line items] | ||
Financial assets | ||
Loans to associates and others [member] | Level 1 [Member] | Loan to A.I Systems [Member] | ||
Disclosure of financial assets [line items] | ||
Financial assets | ||
Loans to associates and others [member] | Level 3 [Member] | ||
Disclosure of financial assets [line items] | ||
Financial assets | 1,036 | 1,002 |
Loans to associates and others [member] | Level 3 [Member] | Loan to Revoltz [Member] | ||
Disclosure of financial assets [line items] | ||
Financial assets | 62 | 62 |
Loans to associates and others [member] | Level 3 [Member] | Loan to Polyrizon [Member] | ||
Disclosure of financial assets [line items] | ||
Financial assets | 80 | |
Loans to associates and others [member] | Level 3 [Member] | Loan to A.I Systems [Member] | ||
Disclosure of financial assets [line items] | ||
Financial assets | 894 | 940 |
Other receivables [member] | ||
Disclosure of financial assets [line items] | ||
Financial assets | 606 | |
Other receivables [member] | Shares receivable [Member] | ||
Disclosure of financial assets [line items] | ||
Financial assets | 606 | |
Other receivables [member] | Level 1 [Member] | ||
Disclosure of financial assets [line items] | ||
Financial assets | 106 | |
Other receivables [member] | Level 1 [Member] | Shares receivable [Member] | ||
Disclosure of financial assets [line items] | ||
Financial assets | 106 | |
Other receivables [member] | Level 3 [Member] | ||
Disclosure of financial assets [line items] | ||
Financial assets | 500 | |
Other receivables [member] | Level 3 [Member] | Shares receivable [Member] | ||
Disclosure of financial assets [line items] | ||
Financial assets | $ 500 |
Financial Instruments (Detail_3
Financial Instruments (Details) - Schedule of Fair Value of Financial Instruments - USD ($) $ in Thousands | 6 Months Ended | ||
Jun. 30, 2023 | Jun. 30, 2022 | ||
Disclosure of detailed information about financial instruments [line items] | |||
Beginning Balance as of January | |||
Net changes at fair value recognized through profit or loss | (328) | $ (404) | |
Shares receivable [Member] | |||
Disclosure of detailed information about financial instruments [line items] | |||
Beginning Balance as of January | |||
Investments in shares, warrants and SAFEs [member] | Level 3 [member] | |||
Disclosure of detailed information about financial instruments [line items] | |||
Beginning Balance as of January | 2,038 | ||
Ending Balance as of December | 1,707 | ||
Purchase of securities | 250 | ||
Net changes at fair value recognized through profit or loss | (267) | ||
SAFE conversion | (314) | ||
Investments in shares, warrants and SAFEs [member] | Safo shares [Member] | Level 1 [member] | |||
Disclosure of detailed information about financial instruments [line items] | |||
Beginning Balance as of January | 10 | ||
Ending Balance as of December | 8 | ||
Purchase of securities | |||
Transfer from equity method | |||
Net changes at fair value recognized through profit or loss | (2) | ||
Sale of securities | |||
Realized loss | |||
Investments in shares, warrants and SAFEs [member] | Tondo shares [Member] | Level 1 [member] | |||
Disclosure of detailed information about financial instruments [line items] | |||
Beginning Balance as of January | 97 | ||
Ending Balance as of December | 101 | ||
Purchase of securities | |||
Transfer from equity method | |||
Net changes at fair value recognized through profit or loss | 4 | ||
Sale of securities | |||
Realized loss | |||
Investments in shares, warrants and SAFEs [member] | A.I Systems shares [Member] | Level 1 [member] | |||
Disclosure of detailed information about financial instruments [line items] | |||
Beginning Balance as of January | |||
Ending Balance as of December | 47 | ||
Purchase of securities | 83 | ||
Transfer from equity method | |||
Net changes at fair value recognized through profit or loss | (36) | ||
Sale of securities | |||
Realized loss | |||
Investments in shares, warrants and SAFEs [member] | Bubbles shares [Member] | Level 1 [member] | |||
Disclosure of detailed information about financial instruments [line items] | |||
Beginning Balance as of January | 151 | ||
Ending Balance as of December | 106 | ||
Purchase of securities | |||
Transfer from equity method | |||
Net changes at fair value recognized through profit or loss | (45) | ||
Sale of securities | |||
Realized loss | |||
Investments in shares, warrants and SAFEs [member] | Hydreight Technologies shares [Member] | Level 1 [member] | |||
Disclosure of detailed information about financial instruments [line items] | |||
Beginning Balance as of January | |||
Ending Balance as of December | 109 | ||
Purchase of securities | 141 | ||
Transfer from equity method | |||
Net changes at fair value recognized through profit or loss | (32) | ||
Sale of securities | |||
Realized loss | |||
Investments in shares, warrants and SAFEs [member] | SciSparc shares [Member] | Level 1 [member] | |||
Disclosure of detailed information about financial instruments [line items] | |||
Beginning Balance as of January | 659 | ||
Ending Balance as of December | 233 | ||
Purchase of securities | 325 | ||
Transfer from equity method | |||
Net changes at fair value recognized through profit or loss | 320 | ||
Sale of securities | (1,045) | ||
Realized loss | (26) | ||
Investments in shares, warrants and SAFEs [member] | Maris shares [Member] | Level 1 [member] | |||
Disclosure of detailed information about financial instruments [line items] | |||
Beginning Balance as of January | 84 | ||
Ending Balance as of December | 110 | ||
Purchase of securities | |||
Transfer from equity method | |||
Net changes at fair value recognized through profit or loss | 26 | ||
Sale of securities | |||
Realized loss | |||
Investments in shares, warrants and SAFEs [member] | Automax warrants [Member] | Level 1 [member] | |||
Disclosure of detailed information about financial instruments [line items] | |||
Beginning Balance as of January | 9 | ||
Ending Balance as of December | 6 | ||
Purchase of securities | |||
Transfer from equity method | |||
Net changes at fair value recognized through profit or loss | (3) | ||
Sale of securities | |||
Realized loss | |||
Investments in shares, warrants and SAFEs [member] | Odysight.ai [Member] | Level 1 [member] | |||
Disclosure of detailed information about financial instruments [line items] | |||
Beginning Balance as of January | |||
Ending Balance as of December | |||
Purchase of securities | |||
Transfer from equity method | [1] | 8,720 | |
Net changes at fair value recognized through profit or loss | [1] | (2,946) | |
Sale of securities | [1] | (5,774) | |
Realized loss | |||
Investments in shares, warrants and SAFEs [member] | ClearMind shares [Member] | Level 1 [member] | |||
Disclosure of detailed information about financial instruments [line items] | |||
Beginning Balance as of January | 594 | ||
Ending Balance as of December | 90 | ||
Purchase of securities | |||
Transfer from equity method | |||
Net changes at fair value recognized through profit or loss | (504) | ||
Sale of securities | |||
Realized loss | |||
Investments in shares, warrants and SAFEs [member] | Elbit shares [Member] | Level 1 [member] | |||
Disclosure of detailed information about financial instruments [line items] | |||
Beginning Balance as of January | 613 | ||
Ending Balance as of December | 578 | ||
Purchase of securities | |||
Transfer from equity method | |||
Net changes at fair value recognized through profit or loss | 185 | ||
Sale of securities | (220) | ||
Realized loss | |||
Investments in shares, warrants and SAFEs [member] | Automax shares [Member] | Level 1 [member] | |||
Disclosure of detailed information about financial instruments [line items] | |||
Beginning Balance as of January | 1,114 | ||
Ending Balance as of December | 341 | ||
Purchase of securities | |||
Transfer from equity method | |||
Net changes at fair value recognized through profit or loss | (773) | ||
Sale of securities | |||
Realized loss | |||
Investments in shares, warrants and SAFEs [member] | Total Financial Instrument [Member] | Level 1 [member] | |||
Disclosure of detailed information about financial instruments [line items] | |||
Beginning Balance as of January | 3,331 | ||
Ending Balance as of December | 1,729 | ||
Purchase of securities | 549 | ||
Transfer from equity method | 8,720 | ||
Net changes at fair value recognized through profit or loss | (3,806) | ||
Sale of securities | (7,039) | ||
Realized loss | (26) | ||
Investments in shares, warrants and SAFEs [member] | Maris warrants [Member] | Level 3 [member] | |||
Disclosure of detailed information about financial instruments [line items] | |||
Beginning Balance as of January | 13 | ||
Ending Balance as of December | 16 | ||
Purchase of securities | |||
Net changes at fair value recognized through profit or loss | 3 | ||
SAFE conversion | |||
Investments in shares, warrants and SAFEs [member] | Polyrizon warrants [Member] | Level 3 [member] | |||
Disclosure of detailed information about financial instruments [line items] | |||
Beginning Balance as of January | 399 | ||
Ending Balance as of December | 117 | ||
Purchase of securities | |||
Net changes at fair value recognized through profit or loss | (282) | ||
SAFE conversion | |||
Investments in shares, warrants and SAFEs [member] | ClearMind warrants [Member] | Level 3 [member] | |||
Disclosure of detailed information about financial instruments [line items] | |||
Beginning Balance as of January | 4 | ||
Ending Balance as of December | 4 | ||
Purchase of securities | |||
Net changes at fair value recognized through profit or loss | |||
SAFE conversion | |||
Investments in shares, warrants and SAFEs [member] | Safee shares [Member] | Level 3 [member] | |||
Disclosure of detailed information about financial instruments [line items] | |||
Beginning Balance as of January | 400 | ||
Ending Balance as of December | 400 | ||
Purchase of securities | |||
Net changes at fair value recognized through profit or loss | |||
SAFE conversion | |||
Investments in shares, warrants and SAFEs [member] | Parazero -SAFE [Member] | Level 3 [member] | |||
Disclosure of detailed information about financial instruments [line items] | |||
Beginning Balance as of January | 520 | ||
Ending Balance as of December | 520 | ||
Purchase of securities | |||
Net changes at fair value recognized through profit or loss | |||
SAFE conversion | |||
Investments in shares, warrants and SAFEs [member] | Polyrizon - SAFE [Member] | Level 3 [member] | |||
Disclosure of detailed information about financial instruments [line items] | |||
Beginning Balance as of January | 302 | ||
Ending Balance as of December | |||
Purchase of securities | |||
Net changes at fair value recognized through profit or loss | 12 | ||
SAFE conversion | (314) | ||
Investments in shares, warrants and SAFEs [member] | Colugo shares [Member] | Level 3 [member] | |||
Disclosure of detailed information about financial instruments [line items] | |||
Beginning Balance as of January | 400 | ||
Ending Balance as of December | 400 | ||
Purchase of securities | |||
Net changes at fair value recognized through profit or loss | |||
SAFE conversion | |||
Investments in shares, warrants and SAFEs [member] | Metagramm shares [Member] | Level 3 [member] | |||
Disclosure of detailed information about financial instruments [line items] | |||
Beginning Balance as of January | |||
Ending Balance as of December | 250 | ||
Purchase of securities | 250 | ||
Net changes at fair value recognized through profit or loss | |||
SAFE conversion | |||
Loans to associates and others [member] | Level 3 [member] | |||
Disclosure of detailed information about financial instruments [line items] | |||
Beginning Balance as of January | 1,002 | ||
Ending Balance as of December | 1,036 | ||
Loans granted to associates and others | 80 | ||
Net changes at fair value recognized through profit or loss | (46) | ||
Loans to associates and others [member] | Loan to Revoltz [Member] | Level 3 [member] | |||
Disclosure of detailed information about financial instruments [line items] | |||
Beginning Balance as of January | 62 | ||
Ending Balance as of December | 62 | ||
Loans granted to associates and others | |||
Net changes at fair value recognized through profit or loss | |||
Loans to associates and others [member] | Loan to A.I. Systems [Member] | Level 3 [member] | |||
Disclosure of detailed information about financial instruments [line items] | |||
Beginning Balance as of January | 940 | ||
Ending Balance as of December | 894 | ||
Loans granted to associates and others | |||
Net changes at fair value recognized through profit or loss | (46) | ||
Loans to associates and others [member] | Loan to Polyrizon [Member] | Level 3 [member] | |||
Disclosure of detailed information about financial instruments [line items] | |||
Beginning Balance as of January | |||
Ending Balance as of December | 80 | ||
Loans granted to associates and others | 80 | ||
Net changes at fair value recognized through profit or loss | |||
Other receivables [member] | Level 1 and Level 3 [member] | |||
Disclosure of detailed information about financial instruments [line items] | |||
Ending Balance as of December | 606 | ||
Shares receivable from the Amendment of the Buffalo Agreement | 937 | ||
Transfer to investments in shares | (178) | ||
Net changes at fair value recognized through profit or loss | (153) | ||
Other receivables [member] | Shares receivable [Member] | Level 1 and Level 3 [member] | |||
Disclosure of detailed information about financial instruments [line items] | |||
Ending Balance as of December | 606 | ||
Shares receivable from the Amendment of the Buffalo Agreement | 937 | ||
Transfer to investments in shares | (178) | ||
Net changes at fair value recognized through profit or loss | $ (153) | ||
[1]For more information, see note 3C. |
Financial Instruments (Detail_4
Financial Instruments (Details) - Schedule of Financial Liabilities that were Measured at Fair Value - USD ($) $ in Thousands | Jun. 30, 2023 | Dec. 31, 2022 |
Disclosure of financial liabilities [line items] | ||
Fair value of warrants | $ 3,300 | $ 4,555 |
Level 1 [Member] | ||
Disclosure of financial liabilities [line items] | ||
Fair value of warrants | 158 | 396 |
Level 3 [Member] | ||
Disclosure of financial liabilities [line items] | ||
Fair value of warrants | $ 3,142 | $ 4,159 |
Financial Instruments (Detail_5
Financial Instruments (Details) - Schedule of Level 1 Financial Liabilities $ in Thousands | 6 Months Ended |
Jun. 30, 2023 USD ($) | |
Level 1 [Member] | |
Schedule of Level 3 financial liabilities [Abstract] | |
Opening balance as of January | $ 396 |
Change in fair value of warrants issued to investors | (238) |
Closing balance as of December | 158 |
Level 3 [Member] | |
Schedule of Level 3 financial liabilities [Abstract] | |
Opening balance as of January | 4,159 |
Change in fair value of warrants in connection with the IPO of Jeffs’ Brands | (1,017) |
Closing balance as of December | $ 3,142 |
Goodwill and Inatangible Asse_3
Goodwill and Inatangible Assets (Details) $ in Thousands | 6 Months Ended |
Jun. 30, 2023 USD ($) | |
Jeffs’ Brands {Member] | |
Goodwill and Inatangible Assets (Details) [Line Items] | |
Intangible assets | $ 2,031 |
Goodwill and Inatangible Asse_4
Goodwill and Inatangible Assets (Details) - Schedule of Company’s Intangible Assets - USD ($) $ in Thousands | Jun. 30, 2023 | Dec. 31, 2022 |
Schedule of Company’s Intangible Assets [Line Items] | ||
Intangible assets, net | $ 31,036 | $ 30,862 |
Technology [Member] | ||
Schedule of Company’s Intangible Assets [Line Items] | ||
Intangible assets | 9,085 | 10,052 |
Customer relationship [Member] | ||
Schedule of Company’s Intangible Assets [Line Items] | ||
Intangible assets | 5,050 | 5,492 |
Software license [Member] | ||
Schedule of Company’s Intangible Assets [Line Items] | ||
Intangible assets | 1,299 | 1,366 |
Patent [Member] | ||
Schedule of Company’s Intangible Assets [Line Items] | ||
Intangible assets | 75 | 75 |
Brand name [Member] | ||
Schedule of Company’s Intangible Assets [Line Items] | ||
Intangible assets | 6,480 | 4,809 |
Goodwilll [Member] | ||
Schedule of Company’s Intangible Assets [Line Items] | ||
Intangible assets | $ 9,047 | $ 9,068 |
Equity (Details)
Equity (Details) - USD ($) $ in Thousands | 1 Months Ended | 6 Months Ended | ||||||
Nov. 14, 2022 | Dec. 31, 2022 | Oct. 31, 2021 | Jun. 30, 2021 | Jun. 30, 2023 | Jun. 09, 2023 | Mar. 02, 2023 | Jun. 17, 2022 | |
Equity (Details) [Line Items] | ||||||||
Number of authorized shares | 200,000,000 | 200,000,000 | ||||||
Post-split ordinary shares | 15 | |||||||
Ordinary shares issued | 24,661,470 | 25,524,570 | 863,100 | 2,500,000 | ||||
Grant shares | 90,000 | 1,280,000 | ||||||
Dividends aggregated amount (in Dollars) | $ 1,582 | |||||||
Recognized expense amount (in Dollars) | $ 276 | |||||||
Bottom of range [Member] | ||||||||
Equity (Details) [Line Items] | ||||||||
Number of authorized shares | 50,000,000 | |||||||
Top of range [Member] | ||||||||
Equity (Details) [Line Items] | ||||||||
Number of authorized shares | 200,000,000 |
Equity (Details) - Schedule of
Equity (Details) - Schedule of Share Capital - Ordinary Shares [Member] - shares shares in Thousands | Jun. 30, 2023 | Dec. 31, 2022 |
Schedule of Share Capital [Abstract] | ||
Number of shares, Authorized | 200,000 | 200,000 |
Number of shares, Issued and paid | 25,525 | 24,661 |
Equity (Details) - Schedule o_2
Equity (Details) - Schedule of Warrants Outstanding | 6 Months Ended | |
Jun. 30, 2023 $ / shares shares | ||
Schedule of Warrants Outstanding [Abstract] | ||
Number of warrants conversion to equivalent ADSs | 217,664 | [1] |
Warrants C [Member] | ||
Schedule of Warrants Outstanding [Abstract] | ||
Date of grant | July 2018 | [2] |
Number of warrants conversion to equivalent ADSs | 176,045 | [1],[2] |
exercise price per warrant in USD | $ / shares | $ 52.5 | [1],[2] |
Expiration date | Jul. 18, 2023 | [2] |
Warrants C [Member] | ||
Schedule of Warrants Outstanding [Abstract] | ||
Date of grant | July 2018 | [3] |
Number of warrants conversion to equivalent ADSs | 28,377 | [1],[3] |
exercise price per warrant in USD | $ / shares | $ 52.5 | [1],[3] |
Expiration date | Jul. 18, 2023 | [3] |
HCW Warrants [Member] | ||
Schedule of Warrants Outstanding [Abstract] | ||
Date of grant | July 2018 | [2] |
Number of warrants conversion to equivalent ADSs | 13,242 | [1],[2] |
exercise price per warrant in USD | $ / shares | $ 65.63 | [1],[2] |
Expiration date | Jul. 18, 2023 | [2] |
[1] Adjusted to reflect the 1:15 ratio change of the Company’s American Depositary Receipt, or ADR, program. As a result, the number of ordinary shares of the Company represented by each American Depositary Share, or ADS, will be changed from one (1) ordinary share to fifteen (15) ordinary shares. The effective date for the ratio change was November 14, 2022 These warrants, under certain circumstances, can be exercised via cashless exercise mechanism as defined in the warrant agreement. Therefore, the warrants were classified as financial liabilities measured at fair value through profit or loss at each reporting period (see note 4). Recorded in equity. |
Transactions and Balances wit_3
Transactions and Balances with Related Parties (Details) - USD ($) | 6 Months Ended | 12 Months Ended | ||
Jun. 30, 2023 | Jun. 30, 2022 | Dec. 31, 2022 | Jan. 23, 2023 | |
Transactions and Balances with Related Parties (Details) [Line Items] | ||||
Aggregate amount | $ 181,000,000 | |||
Description of directors and officers liability insurance | The Company currently has directors’ and officers’ liability insurance providing total coverage of USD 4 million for the benefit of all of the Company directors and officers, in respect of which the Company are charged a twelve-month premium of USD 195, and which includes a deductible of up to USD 1 million per claim, other than securities related claims filed in the United States or Canada, for which the deductible will not exceed USD 2.5 million and USD 5 million in respect of claim with respect to Mergers and Acquisitions. | |||
Additional Share capital1 | 10% | |||
Director [Member] | ||||
Transactions and Balances with Related Parties (Details) [Line Items] | ||||
Benefits of options granted to related parties | 87 | $ 183 | ||
Related Parties [Member] | ||||
Transactions and Balances with Related Parties (Details) [Line Items] | ||||
Benefits of options granted to related parties | $ 56 | $ 160 |
Transactions and Balances wit_4
Transactions and Balances with Related Parties (Details) - Schedule of Transactions with Related Parties - USD ($) $ in Thousands | 6 Months Ended | 12 Months Ended | |
Jun. 30, 2023 | Dec. 31, 2021 | ||
Schedule Of Transactions With Related Parties Abstract | |||
Payroll and related expenses to related parties employed by the Company (1) | [1] | $ 1,032 | $ 496 |
Compensation to directors (2) | [2] | 578 | 418 |
Directors’ and Officers’ insurance | 468 | 453 | |
Consultant services (3) | [3] | 95 | |
Interest and discount amortizations of loans from Jeffs’ Brands related parties (4) | [4] | 40 | |
Finance expense on Screenz payable balance (see note 3D) | 192 | ||
Compensation to member of senior management of Gix Internet (5) | [5] | 102 | |
Eventer sales and marketing expenses to Keshet (see note 3D) | 165 | ||
Eventer revenues from related parties | 15 | 7 | |
Eventer general and administrative expenses to Screenz | 23 | ||
Jeffs’ Brands cost of revenues from related parties (6) | [6] | 313 | |
Jeffs’ Brands income from related parties (7) | [7] | $ 158 | |
[1] Includes granted options benefit in the aggregated amount of USD 56 thousand and USD 160 thousand for the six months period ended June 302023, and 2022, respectively. Also Includes grant of restricted share units (RSUs) in the aggregated amount of USD 181 thousand for the six months period ended June 30, 2023. Includes granted options benefit in the aggregated amount of USD 87 thousand, USD and 183 thousand for the six months period ended June 30, 2023, and 2022, respectively. Includes interest and discount amortizations of loans to Julia Gerasimova, and Victor Hakmon who are related parties of the Company’s subsidiary Jeffs’ Brands. Cortex CTO is a related party of Gix Internet. |
Transactions and Balances wit_5
Transactions and Balances with Related Parties (Details) - Schedule of Current Assets Under Related Parties - USD ($) $ in Thousands | Jun. 30, 2023 | Dec. 31, 2022 |
Schedule of current assets [Abstract] | ||
Advances to Pure Logistics (a related party of Jeffs’ Brands) | $ 7 | $ 228 |
Receivables from SciSparc Nutraceuticals (a related party of Jeffs’ Brands) | 168 | |
Current assets, total | 238 | 298 |
Gix internet [Member] | ||
Schedule of current assets [Abstract] | ||
Other receivables | 58 | 60 |
Eventer [Member] | ||
Schedule of current assets [Abstract] | ||
Other receivables | $ 5 | $ 10 |
Transactions and Balances wit_6
Transactions and Balances with Related Parties (Details) - Schedule of Current Assets Under Loans to Associates - USD ($) $ in Thousands | 6 Months Ended | |
Jun. 30, 2023 | Dec. 31, 2022 | |
Schedule of non current assets [Abstract] | ||
Loan to Laminera (note 3L) | $ 88 | $ 93 |
Loan to Revoltz (note 3H) | 141 | 62 |
Loan to Metagramm (note 3P) | 167 | |
Credit line to Parazero (note 3K) | 785 | 391 |
Curent Assests, Total | $ 1,181 | $ 546 |
Transactions and Balances wit_7
Transactions and Balances with Related Parties (Details) - Schedule of Current Liabilities - USD ($) $ in Thousands | 6 Months Ended | 12 Months Ended | |
Jun. 30, 2023 | Dec. 31, 2022 | ||
Schedule Of Current Liabilities Abstract | |||
Compensation to key management personnel | [1] | $ 685 | $ 649 |
Other payable dividend to related parties of Gix Internet | 284 | ||
Current liabilities to related parties of Jeffs’ Brands | 118 | ||
Other accrued expenses to related parties of Eventer | 8 | 122 | |
Current liabilities, total | $ 811 | $ 1,055 | |
[1]As of June 30, 2023, these balances include compensation to key management personnel of the Company, Eventer, Gix Internet, Fuel Doctor and Jeffs’ Brands. |
Revenues (Details)
Revenues (Details) | 6 Months Ended |
Jun. 30, 2023 | |
Revenue [Abstract] | |
Company revenue | 10% |
Revenues (Details) - Schedule o
Revenues (Details) - Schedule of Group’s Revenues Disaggregated by Revenue - USD ($) $ in Thousands | 6 Months Ended | ||
Jun. 30, 2023 | Jun. 30, 2022 | ||
Schedule of Group 's Revenues Disaggregated by Revenue | |||
Revenues from commissions (from Eventer) | $ 1,498 | $ 1,472 | |
Products (from Jeffs’ Brands) | 3,871 | 2,343 | |
Revenues from internet services (from Gix Internet) | 48,016 | (31,144) | [1] |
Disaggregation of revenues | $ 53,385 | $ 34,959 | |
[1] The revenues from Gix Internet are presented for the period from March 1, 2022, to June 30, 2022. |
Revenues (Details) - Schedule_2
Revenues (Details) - Schedule of Breakdown of Company’s Revenue by Major Customers - USD ($) $ in Thousands | 6 Months Ended | |
Jun. 30, 2023 | Jun. 30, 2022 | |
Customer A [Member] | ||
Schedule of Breakdown of Company’s Revenue by Major Customers | ||
Revenue from customer | $ 7,753 | $ 6,458 |
Customer B [Member] | ||
Schedule of Breakdown of Company’s Revenue by Major Customers | ||
Revenue from customer | $ 8,109 | $ 5,124 |
Segments (Details)
Segments (Details) $ in Thousands | 6 Months Ended |
Jun. 30, 2023 USD ($) | |
Gix internet [Member] | |
Segments (Details) [Line Items] | |
Equity loss | $ 215 |
Parazero [Member] | |
Segments (Details) [Line Items] | |
Investments | 592 |
Equity method investment | 384 |
Laminera [Member] | |
Segments (Details) [Line Items] | |
Investments | 1,142 |
Equity method investment | 34 |
Polyrizon [Member] | |
Segments (Details) [Line Items] | |
Investments | 643 |
Equity method investment | 65 |
Odysight.ai. [Member] | |
Segments (Details) [Line Items] | |
Equity method investment | 655 |
Equity loss | $ 1,073 |
Segments (Details) - Schedule o
Segments (Details) - Schedule of Group’s Segments Based on Operating Loss (Income), Assets and Liabilities - USD ($) $ in Thousands | 6 Months Ended | |||||
Jun. 30, 2023 | Jun. 30, 2022 | Dec. 31, 2022 | ||||
Schedule of Group’s Segments Based on Operating Loss (Income), Assets and Liabilities [Line Items] | ||||||
Total segments’ assets | $ 85,667 | $ 97,651 | ||||
Total segments’ liabilities | (41,220) | (42,962) | ||||
External revenue | 53,385 | $ 34,959 | ||||
Segment results - operating income (loss) | (9,790) | (6,328) | ||||
Non-operating income (loss) | 1,409 | 2,382 | ||||
Finance income (loss) | (978) | (793) | ||||
Profit (Loss) before taxes on income | (9,359) | (4,739) | ||||
Tax benefit (expense) on income | (177) | (9) | ||||
Segment results - profit (loss) | (9,536) | (4,748) | ||||
Corporate [Member] | ||||||
Schedule of Group’s Segments Based on Operating Loss (Income), Assets and Liabilities [Line Items] | ||||||
Total segments’ assets | 16,660 | 19,478 | ||||
Total segments’ liabilities | (1,204) | (1,198) | ||||
External revenue | ||||||
Segment results - operating income (loss) | (6,301) | (3,366) | ||||
Non-operating income (loss) | 157 | 64 | ||||
Finance income (loss) | (219) | 330 | ||||
Profit (Loss) before taxes on income | (6,363) | (2,972) | ||||
Tax benefit (expense) on income | 3 | (5) | ||||
Segment results - profit (loss) | (6,360) | (2,977) | ||||
E-commerce [Member] | ||||||
Schedule of Group’s Segments Based on Operating Loss (Income), Assets and Liabilities [Line Items] | ||||||
Total segments’ assets | 16,096 | 15,667 | ||||
Total segments’ liabilities | (5,500) | (5,025) | ||||
External revenue | 3,871 | 2,343 | ||||
Segment results - operating income (loss) | (2,131) | (1,098) | ||||
Non-operating income (loss) | 1,252 | (63) | ||||
Finance income (loss) | (193) | (272) | ||||
Profit (Loss) before taxes on income | (1,072) | (1,433) | ||||
Tax benefit (expense) on income | (9) | (93) | ||||
Segment results - profit (loss) | (1,081) | (1,526) | ||||
Online Advertising & Internet Traffic Routing [Member] | ||||||
Schedule of Group’s Segments Based on Operating Loss (Income), Assets and Liabilities [Line Items] | ||||||
Total segments’ assets | 45,680 | 50,999 | ||||
Total segments’ liabilities | (31,868) | (33,203) | ||||
External revenue | 48,016 | |||||
Segment results - operating income (loss) | (46) | |||||
Non-operating income (loss) | ||||||
Finance income (loss) | (765) | |||||
Profit (Loss) before taxes on income | (811) | |||||
Tax benefit (expense) on income | (340) | |||||
Segment results - profit (loss) | (1,151) | |||||
Online Event Management [Member] | ||||||
Schedule of Group’s Segments Based on Operating Loss (Income), Assets and Liabilities [Line Items] | ||||||
Total segments’ assets | 3,936 | 3,208 | ||||
Total segments’ liabilities | (2,821) | (3,244) | ||||
External revenue | 1,498 | 1,472 | ||||
Segment results - operating income (loss) | 140 | (310) | ||||
Non-operating income (loss) | ||||||
Finance income (loss) | (55) | (277) | ||||
Profit (Loss) before taxes on income | 85 | (587) | ||||
Tax benefit (expense) on income | ||||||
Segment results - profit (loss) | 85 | (587) | ||||
Others [Member] | ||||||
Schedule of Group’s Segments Based on Operating Loss (Income), Assets and Liabilities [Line Items] | ||||||
Total segments’ assets | [1] | 11,368 | ||||
Total segments’ liabilities | (177) | (952) | ||||
External revenue | ||||||
Segment results - operating income (loss) | (1,452) | [2] | (1,385) | [3] | ||
Non-operating income (loss) | 137 | |||||
Finance income (loss) | (7) | (2) | ||||
Profit (Loss) before taxes on income | (1,459) | (1,250) | ||||
Tax benefit (expense) on income | (6) | |||||
Segment results - profit (loss) | (1,459) | (1,256) | ||||
Adjustments [Member] | ||||||
Schedule of Group’s Segments Based on Operating Loss (Income), Assets and Liabilities [Line Items] | ||||||
Total segments’ assets | (293) | (3,069) | ||||
Total segments’ liabilities | 350 | $ 660 | ||||
External revenue | ||||||
Segment results - operating income (loss) | (807) | |||||
Non-operating income (loss) | 2,300 | |||||
Finance income (loss) | 261 | 48 | ||||
Profit (Loss) before taxes on income | 261 | 1,541 | ||||
Tax benefit (expense) on income | 169 | 110 | ||||
Segment results - profit (loss) | $ 430 | 1,651 | ||||
Online Advertising [Member] | ||||||
Schedule of Group’s Segments Based on Operating Loss (Income), Assets and Liabilities [Line Items] | ||||||
External revenue | 31,144 | |||||
Segment results - operating income (loss) | [4] | 638 | ||||
Non-operating income (loss) | (56) | |||||
Finance income (loss) | (620) | |||||
Profit (Loss) before taxes on income | (38) | |||||
Tax benefit (expense) on income | (15) | |||||
Segment results - profit (loss) | $ (53) | |||||
[1]Includes investments accounted for using the equity method of USD 592 thousand in relation to Parazero (note 3K), USD 1,142 thousand in relation to Laminera (note 3L) and USD 643 thousand in relation to Polyrizon (note 3G).[2]Includes equity losses of USD 655 thousand in relation to Odysight.ai (note 3C), USD 384 thousand in relation to Parazero (note 3K), USD 34 thousand in relation to Laminera (note 3L) and USD 65 thousand in relation to Polyrizon (note 3G).[3]Includes equity loss of USD 1,073 thousands in relation to Odysight.ai.[4]Includes equity loss of USD 215 thousands in relation to Gix Internet. |
Subsequent Events (Details)
Subsequent Events (Details) - USD ($) $ in Thousands | 1 Months Ended | ||||||||
Sep. 13, 2023 | Sep. 05, 2023 | Aug. 01, 2023 | Jul. 11, 2023 | Jul. 03, 2023 | Apr. 06, 2023 | Jul. 31, 2023 | Jul. 20, 2023 | Jun. 30, 2023 | |
Subsequent Events (Details) [Line Items] | |||||||||
Aggregated gross proceeds | $ 3,500 | ||||||||
Loan amount | $ 250 | ||||||||
Converted shares | 2,650,423 | ||||||||
Initial Public Offering [Member] | |||||||||
Subsequent Events (Details) [Line Items] | |||||||||
Converted shares | 173,836 | ||||||||
Subsequent Event [Member] | |||||||||
Subsequent Events (Details) [Line Items] | |||||||||
Share issued | 169,920 | ||||||||
Sale of consideration | $ 5,700 | ||||||||
RSUs granted | 51,020 | ||||||||
Percentage of decreased holding | 33.36% | ||||||||
Loan amount | $ 785 | ||||||||
Additional shares | 21,000 | ||||||||
Percentage of issued and outstanding shares | 36% | ||||||||
Joint venture percentage | 60% | ||||||||
Percentage of remaining initial contribution | 40% | ||||||||
Percentage of property interest | 30% | ||||||||
Subsequent Event [Member] | Miami [Member] | |||||||||
Subsequent Events (Details) [Line Items] | |||||||||
Invested amount | $ 2,000 | ||||||||
Subsequent Event [Member] | Initial Public Offering [Member] | |||||||||
Subsequent Events (Details) [Line Items] | |||||||||
Aggregated gross proceeds | 7,800 | ||||||||
Converted ordinary shares | $ 1,500 |